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ABSTRACT 
 
Damon Floyd Ogburn: Entry into HIV medical care, receipt of case management services, 
depression, and ART adherence among adults with HIV in North Carolina 
(Under the direction of Victor J. Schoenbach) 
 
 
Engagement in HIV care is important for optimal clinical outcomes and reductions in 
transmission, particularly in Southern states. Delayed care initiation remains prevalent. While 
individual-level risk factors are established, barriers to prompt care initiation associated with 
characteristics of HIV testing facilities are not well defined. Upon care initiation, persons may 
benefit from the provision of case management services. Little has been published about whether 
case management services reduce depression or improve ART adherence.  
We analyzed 2015 enhanced HIV/AIDS Reporting System data for North Carolina (NC) 
to estimate the cumulative incidence of persons initiating HIV care by time since diagnosis and 
in relation to (1) patient-level characteristics and (2) characteristics of the facility where HIV was 
diagnosed. Of 1,269 adults newly diagnosed in 2015, 84.9% were linked to care < three months 
from diagnosis; 63% initiated care within one month. Initiating care at ≥ three months was 
associated with younger age, IDU transmission, diagnosis at a site without co-located HIV care 
among males but not females, diagnosis at a facility with a higher diagnosis volume, and 
diagnosis at a sexually transmitted disease clinic (STD), HIV counseling and testing site, or a 
non-traditional testing facility setting such as a jail. 
For the examination of persons in HIV care, we used NC data for 2009-2013 from the 
Medical Monitoring Project. Depression prevalence was higher among the 53.2% who had 
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received case management services than among those who had not, though the adjusted 
association was observed only among patients living above the poverty level. No differences in 
ART adherence were observed by receipt of case management services. Though ART adherence 
was high overall, depressed persons with HIV were less likely to be adherent.   
HIV clinicians, case managers, and intervention specialists working with persons 
diagnosed at high volume STD clinics, HIV counseling and testing sites, and non-traditional 
testing facilities should be provided with resources to ensure persons are promptly enrolled in 
care. Depression persisted, suggesting the need for resources for case managers, providers, and 
mental health professionals. Combining data sources for persons living with HIV will be 
essential to monitor the HIV continuum in NC. 
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CHAPTER ONE: OVERVIEW 
 
 
Interventions focused on persons living with the human immunodeficiency virus (HIV) 
are of great importance for reducing HIV comorbidities, improving clinical outcomes and 
survival, and preventing further transmission. Initial HIV prevention strategies focused on 
reductions in sexual partners,1 changes in sexual behaviors,1-3, increase in condom usage,2, 3 and 
abstinence.3 Although these behavioral approaches have been shown to be effective at reducing 
HIV transmission, the more recent “test-and-treat” strategy is much more powerful.4 Early HIV 
detection with prompt linkage to HIV medical care including initiation of and adherence to 
antiretroviral (ART) therapy dramatically reduces HIV transmission.4, 5 
 Despite widespread endorsement of the new strategy, failure to promptly initiate care 
upon initial detection is common, leading to ongoing HIV transmission and more rapid 
progression to the acquired immune deficiency syndrome (AIDS) as defined by CD4 criteria.6 A 
meta-analysis of time to enter care between 1995 and 2009 found that 28% of HIV-positive 
people entered care more than 3 months after initial diagnosis.7 A study measuring access to HIV 
primary care in the St. Louis, MO area found that 10% to 20% of newly diagnosed individuals 
did not enter care even after three years following diagnosis.8 In Southern states 
disproportionately affected by HIV, the prevalence of delayed linkage to HIV medical care 
among people living with HIV is not clear. Factors such as sex,9, 10 age,9-12 race,13-15 
socioeconomic status,12, 13 health insurance,14-16 geographic location,12, 13 education,12 and mental 
health status12 have been associated with delayed entry into HIV medical care. Several studies 
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have demonstrated that initial HIV diagnosis at larger medical facilities in urban areas or at 
facilities with co-located HIV clinical care significantly decreased delayed entry into HIV 
medical care.10, 17-20 The type of facility at initial HIV diagnosis may also be a factor. In New 
York City surveillance data, patients diagnosed at a community testing site, city correctional 
system, and sexually transmitted disease (STD) or tuberculosis (TB) clinic were less likely to 
initiate HIV medical care within three months of initial diagnosis than patients diagnosed at sites 
with co-located medical care.20 
 Further along the HIV care continuum,21 according to a meta-analysis of 31 ART 
adherence studies, only 55% of HIV-infected persons reached adequate levels of adherence upon 
initiation of and linkage to HIV medical care.22 ART adherence is essential to achieve good 
clinical and immunologic outcomes, particularly viral suppression.23-25 Given how crucial viral 
suppression is both to patient survival and also to preventing further transmission,6 it is also 
important to address any unmet needs that may compromise ART adherence and viral 
suppression. Depression, the most prevalent psychiatric disorder among HIV-infected patients 
other than substance use disorders, has serious effects on a patient’s quality of life and course of 
illness.26 Numerous prospective and cross-sectional studies have demonstrated significant 
associations of depression or depressive symptoms with ART non-adherence and 
discontinuation,25, 27-29 and poorer virological response and immunological failure.23, 30, 31 
 One approach to facilitating treatment of depression or depressive symptoms among 
HIV-infected persons is the provision of case management services. Several studies of case 
management services for recently diagnosed, persons with HIV reported greater linkage to care, 
receipt of ART, and virologic success.19, 32-34 However, few studies have examined the utilization 
of case management services in relation to unmet psychosocial and social service needs among 
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persons with HIV who have initiated HIV care. HIV patients who were aware of their status but 
had not been retained in care within the past six months or never initiated care had lower mental 
health scores than persons who received some HIV care services, and did not have case 
managers.35 
 The goal of the present research is to examine (1) potential patient and testing facility 
barriers to linkage to care, and (2) the use of HIV case management services in relation to HIV-
related mental health and clinical outcomes. Using North Carolina (NC) data from two national 
surveillance databases – the enhanced HIV/AIDS Reporting System (eHARS, 2015) and the 
Medical Monitoring Project (MMP, 2009-2013) – we will address the following aims: 
1.1 Aim 1 
 
Specific Aim 1. Estimate the cumulative incidence of persons initiating HIV medical 
care following diagnosis, examine patient-level sociodemographic and behavioral 
characteristics associated with delay in initiating care, and assess time to care initiation in 
relation to characteristics of the facility where HIV was diagnosed. 
1.2 Aim 2 
 
Specific Aim 2. Estimate the prevalence of probable current depression and 100% ART 
dose adherence in the past three days in relation to the receipt of case management 
services in the previous 12 months.  
The proposed research aims to identify barriers along the HIV care continuum in North 
Carolina, where HIV/AIDS incidence is higher than the national average. Results can be used to 
evaluate areas for improvement in linkage to HIV medical care and to assess the utilization of 
case management support services in relation to depression and ART adherence, which 
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ultimately affect retention in care and the achievement of optimal clinical and survival outcomes 
for persons living with HIV as well as preventing further transmission of the virus. 
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CHAPTER TWO: BACKGROUND AND SIGNIFICANCE 
 
2.1 HIV Epidemic in the Southern United States 
 
 The Centers for Disease Control and Prevention (CDC) estimate that more than 1.2 
million people living in the United States (US) are infected with HIV. Approximately 1 in 8 
(~13%) HIV-infected persons are unaware of their HIV status.36 The number of incident cases 
remains stable at approximately 50,000 cases per year; however, several subpopulations are 
disproportionately affected. Blacks represent 12% of the U.S. population but accounted for 
approximately 44% of new HIV infections in 2010. Hispanics represent 16% of the population, 
but accounted for roughly 21% of incident infections in the same year. Approximately 62% of 
persons receiving an HIV diagnosis in 2011 were men who have sex with men (MSM).36 Young 
black MSM between the ages of 18 and 30 are at greatest risk for HIV infection.37 
 The District of Columbia and sixteen states that comprise the Southern region of the US 
carry a severe HIV burden.38 Six southern states (NC, South Carolina, Alabama, Georgia, 
Louisiana, Mississippi) – the Deep South39 – have similar HIV/AIDS epidemic profiles. The 
Deep South has a history of challenges including high STD rates, poor medical infrastructures, 
high poverty levels, and considerable numbers of persons lacking health insurance. Minority 
groups, particularly blacks, are disproportionately affected by these factors, which are related to 
the higher HIV/AIDS incidence rates observed in this region.39, 40  
By the end of 2013, approximately 36,300 people were living with HIV infection in 
NC.41 An estimated 6,500 (17.9%) were unaware of their HIV status. During 2013, 1,525 
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individuals were newly diagnosed, including 1,513 over 13 years of age, for an adult/adolescent 
incidence rate of 18.7 per 100,000/year.41 By 2015, the most recent year for which data are 
available, the number of adult/adolescent incident HIV cases diagnosed had decreased to 1,336, 
an HIV incidence rate of 15.9 per 100,000/year.42 Although incidence decreased, the high rates 
of undiagnosed and untreated HIV, along with aforementioned factors, enable ongoing HIV 
transmission. Moreover, 2015 adult/adolescent HIV incidence in NC continued to be much 
higher in the black population, with their share of new diagnoses nearly twice the percentage of 
blacks in the state’s adult/adolescent population.42 
 Challenges to removing barriers to HIV testing and treatment in NC, particularly among 
minorities, include historical factors specific to the Deep South. Two more commonly described 
challenges are poverty and rurality, which limit access to healthcare. Between 2009 and 2010, 
19% of the 19-64 year old population was at or below the federal poverty line.43 Since NC has 
not adopted the Affordable Care Act’s Medicaid expansion, persons above the poverty line may 
have even greater difficulty accessing healthcare than the poor.44 In 2006, the CDC reported that 
NC had the highest rate of HIV and AIDS cases in rural areas.43 Since most HIV care 
management is available only in urban areas, HIV-infected rural residents often travel significant 
distances to receive care.45 Rural communities often experience shortages of trained medical and 
mental health professionals,40, 46 lack of public and personal transportation,40, 46 lack of 
knowledge regarding HIV prevention,46 and few systems of support and counseling for HIV-
infected persons.45, 46 In addition, persons living with HIV in rural areas face greater stigma from 
community members than persons living in or near urban areas.39 
 With the continuing problem of HIV and an especially high HIV burden among specific 
subpopulations, there remains a need for research to identify specific barriers that impede HIV 
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testing, treatment initiation, and adherence, as well as potential facilitators including counseling 
and case management services, to assist NC HIV prevention strategists in fielding interventions 
that reduce transmission. 
2.2 HIV Prevention Strategies 
 
  In 2003, the CDC along with other government agencies released guidelines for 
incorporating HIV prevention into the medical care of HIV-infected persons. New and existing 
strategies such as risk screening, behavioral interventions, and partner notification and 
counseling were suggested in these guidelines.47 In 2010, the US government created a plan 
known as the ‘The National HIV/AIDS Strategy’ (NHAS) with a goal of addressing the national 
HIV epidemic. Building on the strategies implemented in 2003, the Strategy has three main 
goals: reduce HIV incidence; increase access to care and optimize health outcomes for people 
living with HIV; and reduce HIV-related health disparities. In addition, the strategy set an overall 
goal of reducing HIV incidence by 25% by the year 2015.48 States with a high HIV burden, such 
as NC, and metropolitan cities serve as focal points, as described by specific action steps listed 
within the proposed strategy. In 2014, the federal government allotted a total of $29.5 billion 
towards combating HIV, with the majority (55%) for HIV care and the least amount (3%) for 
HIV prevention services.49 
 Prevention services vary on both state and local levels, and often include involvement 
with community organizations. Early HIV prevention strategists focused on reductions in sexual 
partners,1 reductions in risky sexual behaviors,1-3 increased condom usage 2, 3 and abstinence.3 
However, the primary focus shifted towards identification of HIV-infected persons through 
routine testing and linkage to care. An additional objective was to increase the number of persons 
who are aware of their HIV serostatus to 90% or better by 2015.48 The goals set in 2010, as well 
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as lessons learned, contributed to ‘The National HIV/AIDS Strategy: Updated to 2020’ in 2015. 
This Strategy maintains the original plan of action outlined in 2010 with an additional goal of 
achieving a more coordinated national response to HIV. Emphasis is now placed on increasing 
testing; linking and retaining in care 85% of HIV-infected persons within one month of 
diagnosis; and achieving viral suppression among 80% of persons living with HIV. In addition, 
the Strategy aims to increase access to pre-exposure prophylaxis (PrEP). A focus on 
subpopulations with the highest rates remains key.50 
 In 2011 the landmark HIV Prevention Trials Network (HPTN) 052 phase III clinical trial 
assessing the effects of early initiation of antiretroviral (ARV) therapy on heterosexual HIV 
transmission among serodiscordant couples reported that immediate treatment reduced HIV 
transmission by 96%;51 efficacy was 93% at the trial’s conclusion in 2016. Among the 1,171 
heterosexual couples with complete follow-up data, 78 HIV infections occurred. A total of 46 out 
of 78 infections were partner-linked. Approximately 93% (n=43) of these infections occurred 
among partnerships where the HIV-infected person delayed initiation of ART treatment.52, 53  
Findings are expected to be comparable within the homosexual community as well. The 
ongoing PARTNERS Study, which has enrolled over 1,000 serodiscordant couples (40% 
homosexual) has not reported any transmissions among couples where the HIV-infected person 
has an undetectable viral load.54 These findings have shaped the way in which HIV prevention 
efforts are guided worldwide. World Health Organization guidelines now recommend immediate 
ART treatment for all HIV-infected persons regardless of CD4 count.55 Clinicians no longer 
recommend waiting until CD4 counts fall below a particular threshold. Studies have shown that 
immediate treatment also results in a reduction in the risk of death or serious illness.56 
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 Treatment as prevention has also evolved among persons at high risk of infection. The 
Pre-exposure Prophylaxis Initiative trial was an international study evaluating the efficacy and 
safety of once daily Truvada® for the prevention of HIV among men and transgender women 
who have sex with men. Truvada® was shown to provide 44% protection from HIV 
acquisition.57 ARV prophylaxis for HIV prevention was also assessed among heterosexual 
partners. A randomized trial following 4,747 couples conducted in Kenya and Uganda reported a 
67% relative reduction in the incidence of HIV among persons taking once-daily tenofovir and a 
75% relative reduction in the incidence of HIV among persons taking Truvada®.58 Given the 
efficacy of PrEP, the Food and Drug Administration approved its use in July 2012. In 2014, 
clinical practice guidelines were released to assist clinicians with prescribing PrEP and providing 
additional resources to their patients.50 
2.3 The HIV Care Continuum 
 
Effective test-and-treat HIV prevention strategies require identification and elimination 
of barriers along each step of the HIV care continuum, depicted in Figure 1. In 2013, President 
Obama and the White House administration established the HIV Care Continuum Initiative to 
accelerate progress towards this goal.49 Specifically, the administration identified the following 
points along the continuum as requiring the greatest improvements: 1) awareness of status, 2) 
linkage to care, 3) engagement in care and 4) viral suppression.50 With emphasis on the 
importance of the test-and-treat strategy, national testing efforts have increased. However, a 
large number of newly diagnosed, HIV-infected persons have already advanced to full blown 
AIDS by the time of diagnosis. High levels of viremia may lead to HIV comorbidities and 
increased likelihood of transmission to uninfected partners.51 It is important to identify 
deficiencies in HIV control measures among subpopulations disproportionately affected by HIV. 
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Figure 1 The HIV care continuum 
 
 
 
 
(Adapted from Gardner et al. 2011) 
 
Besides the delay in diagnosing HIV, there is also delay in care initiation after diagnosis. 
In the US, delayed entry into HIV medical care is common. An estimated 75% of newly 
diagnosed persons initiate care six to twelve months after initial HIV diagnosis, while only 80%-
90% link to care within three to five years.59 In NC some 30,000 cases of HIV have been 
diagnosed and reported by the end of 2013 (Figure 2). Although the true number of persons 
seeking care was likely understated due to incomplete laboratory reporting, roughly half of these 
HIV-infected persons had one care visit during calendar year 2013. Approximately two-thirds of 
HIV-infected persons receiving at least one care visit in 2013 had a second visit three or more 
months later within the same year. In addition, viral suppression was documented for only 36.4% 
of the total cases.41 
Diagnosed 
with HIV 
Linked to 
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retained in 
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Figure 2 HIV care continuum among people with last known residence in North Carolina, 
2009-2013 
 
a2013 data are overestimated due to reporting delays for death information 
bLegend: year shown refers to the year in which care measures were evaluated; cases were diagnosed and reported 
between the beginning of the epidemic and the end of the prior year. 
Source: 2013 North Carolina HIV/STD Epidemiologic Profile 
 
In 2015, additional data sources were available to measure points along the HIV care 
continuum in NC, including Ryan White (RW) service data, CAREWare, laboratory claims from 
Medicaid, and ARV medications dispensed from the AIDS Drug Assistance Program (ADAP) 
and Medicaid.60 Of an estimated 35,700 persons living with HIV infection in NC in 2015, 32,130 
(90%) were diagnosed and reported though 2014. Approximately 71% of those diagnosed and 
reported had at least one care marker (e.g., viral load (VL), CD4) in a year, and 59% were virally 
suppressed.60 While these percentages were an improvement from previous estimates, barriers 
along each point of the continuum prevent many HIV-infected persons from ultimately achieving 
viral suppression. 
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2.4 Delayed Entry into HIV Medical Care 
 
 An estimated 17% to 29% of HIV-infected individuals do not enter care within six 
months of initial HIV diagnosis or initial clinic appointment (Table 1). The estimates vary on the 
basis of sample design and the defined time to entry to care.7, 9, 10, 14, 16, 19, 20, 61 One prospective, 
five-year surveillance study conducted in St. Louis, Missouri reported that only 73% of newly 
diagnosed persons had evidence of an HIV primary care visit from 1998-2002.8 Based on 
surveillance data for New York City residents diagnosed in 2003, 63.7% of newly diagnosed, 
HIV-infected persons initiated care within three months of diagnosis.20 A study conducted in 
New York City using MMP surveillance data from 2007-2008 reported that among 513 persons 
in HIV care at the time of interview, 23% had entered care more than three months after initial 
diagnosis.10 
 
Table 1 Studies examining delayed entry into HIV medical care 
 
 
Source Sample Design Sample % Delayed
> 3 months delayed entry into HIV care since baseline
Turner et al. (Arch Intern Med, 2000) national probability 
sample of persons in care
n = 1540, diagnosed by 
02/93 and in care ≤ 3 years
29%
Turner et al. (Arch Intern Med, 2000) national probability 
sample of persons in care
n = 1960, diagnosed by 
02/95 and in care ≤ 1 year
17%
Torian et al. (Arch Intern Med, 2008) New York City 
surveillance data
n = 1,928 19%
Reed et al. (AIDS Patient Care STDS, 2009) US facility and population-
based surveillance data
n = 3,942 28%
Jenness et al. (AIDS Care, 2012) national probability 
sample of persons in care
n = 513 23%
> 4 months delayed entry into HIV care since baseline
Marks et al. (AIDS, 2010) meta-analysis n = 6,586 28%
> 6 months delayed entry into HIV care since baseline
Turner et al. (Arch Intern Med, 2000) national probability 
sample of persons in care
n = 1540, diagnosed by 
02/93 and in care ≤ 3 years
21%
> 12 months to delayed entry into HIV care since baseline
Gay et al. (AIDS, 2006) convenience sample n = 348 (note: 37% 
initiated care at least once 
prior to study)
32%
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The Supplement to HIV/AIDS Surveillance Project was a cross-sectional interview study 
designed to collect behavioral data from adults with HIV, most of whom had entered HIV care, 
in 18 states from 2000-2004. Among 3,942 respondents, 28% had delayed entry to care defined 
as three months or longer after initial diagnosis.16 The Antiretroviral Treatment Access Study 
(ARTAS) examined time to care among recently diagnosed, HIV-infected persons in Atlanta, 
Baltimore, Los Angeles, and Miami. Only 60% of patients who received passive referrals to care 
linked to care within six months of initial diagnosis.12 One cross-sectional study among patients 
living in NC initiating HIV medical care between 2000 and 2003 at the University of North 
Carolina HIV outpatient clinic reported that 32% of patients did not initiate care for at least one 
year after initial diagnosis.9 
Factors associated with delayed entry into care include minority race14, 15, injection drug 
use,16 unemployment,16 travel distance to care,13 lacking private health insurance,14-16 initial 
detection in a nonmedical environment,20 and scheduling lag, defined as the time from the call to 
schedule a first patient visit to the appointment date.14 Factors commonly identified as associated 
with difficulties in accessing HIV care in NC include rural residence, stigma, lack of 
transportation, and relatively few HIV-trained practitioners.40 Race/ethnicity13 and even laws and 
healthcare policies specific to some Southern states are relatively frequent barriers as well.62 
Overall, though, little has been published detailing the relation of these patient 
characteristics, as well as of testing facility factors, to delayed entry to HIV medical care. In 
other areas of healthcare, co-location of medical services has been found to be significantly 
associated with more effective service delivery and better outcomes, which could have important 
implications for HIV linkage to care programs. One study examined no-show rates in 
coordinated vs. co-located integrated models of behavioral health care. Coordinated behavioral 
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health care was provided at a location separate from the primary care physician. Co-located care 
was provided in the same location as the primary care physician. Results showed that, among 
Medicaid patients, no-show rates for the co-located care group were significantly lower than for 
the coordinated care group (p = 0.001), which has important implications for integrating services 
into the offices of physicians, particularly for vulnerable populations.63 A randomized trial 
assessed the efficacy of an integrated model of primary medical care for veterans with severe 
mental disorders. The integrated medical care clinic provided patients with on-site primary care 
as well as case management with collaboration from mental health providers. Researchers found 
that patients treated in the integrated care clinic were significantly more likely to have made a 
primary care visit, had greater average number of primary care visits, and had a significantly 
greater improvement in health as measured by a 36-Item Short-Form Health Survey.64 
With regard to linkage to HIV medical care, The ARTAS-I was a CDC sponsored, two-
arm randomized controlled trial comparing a brief strengths-based case management intervention 
with standard-of-care referral in linking recently diagnosed, HIV-infected persons to care. Due to 
successful, timely entry in the arm receiving case management services, ARTAS-II was funded 
to evaluate the same model in local and health state departments and community-based 
organizations (CBOs). Researchers used data from the ARTAS-II project, site visits, and project 
director reports to examine factors associated with timely linkage to HIV medical care. From 
October 2004 – June 2007, ARTAS-II obtained structural factor data from ten health 
departments or CBOs in rural, mid-sized and urban locations. Researchers found that in these 
settings, sites with co-located HIV medical care services had better linkage to care rates than non 
co-located sites (87% vs. 73%).19 
 15
Most research examining testing facility characteristics and time to entry into HIV 
medical care has assessed linkage models at large medical facilities or emergency departments in 
larger cities often co-located with HIV testing facilities. The rates of linkage to care within three 
months were often greater than 80-85%.17, 18 However, even in large cities, initial diagnosis at 
sites in nonmedical environments (versus medical environments)10 or sites without co-located 
HIV care (versus sites with co-located HIV care) was associated with delayed entry to care 
[community testing site (hazard ratio [HR], 1.9; 95% confidence interval [CI], 1.5-2.3); city jail 
(HR, 1.6; 95% CI, 1.2-2.0); STD/TB clinic (HR, 1.3; 95% CI, 1.1-1.6)].20  
Notwithstanding the advantages of testing in facilities which have HIV medical care 
onsite, it is also important to consider how testing sites without co-located HIV medical care can 
facilitate patient initiation of care, since such sites detect many cases of HIV that would 
otherwise have gone undetected. This phenomenon is particularly relevant in resource-limited 
settings where access to medical care can be problematic, and a great need for general testing 
services remains. Thus, additional research is needed to assess the impact of various testing 
facility types on delayed entry into care in urban and rural settings in southern states such as NC 
and with a focus on subpopulations experiencing the highest rates of new HIV infections. 
2.5 HIV and Depression 
 
 Once an HIV-infected person is engaged in care, it is crucial to address unmet needs that 
can compromise patient adherence and achievement of viral suppression. Depression, the most 
prevalent psychiatric disorder among HIV-infected patients after substance use disorders, has 
important implications for patient retention and quality of life.26 Chander et al. reviewed 
depression prevalence estimates in the US among small, regional subpopulations of HIV-infected 
individuals prior to 2000, and reported estimates as high as 48%.65 More recent prevalence 
 16
estimates of depression among HIV-infected persons engaged in care range from 20% - 30%.66 
These estimates are at least twice those of general population national depression prevalence 
estimates, which range from 4% - 7% based on data from the Behavioral Risk Factor 
Surveillance System.67, 68 A 2014 study using national surveillance data for HIV-infected persons 
in care reported a 12.4% prevalence of major depression (95% CI, 11.2-13.7) and a 13.2% 
prevalence of other depression (95% CI, 12.0-14.4).68  
Numerous prospective and cross-sectional studies have examined associations of 
depression or depressive symptoms with ART adherence, viral load, and immunological 
outcomes. A nested cohort analysis of 873 HIV-infected men in the Multicenter AIDS Cohort 
Study examined predictors and effects of highly active antiretroviral therapy (HAART) 
interruption and discontinuation. Approximately 28% of the study population was depressed, 
based on a Center for Epidemiologic Studies Depression (CES-D) Scale score greater than 15. 
Depression was significantly associated with HAART interruption [(adjusted odds ratio (aOR), 
1.97; 95% CI, 1.38-2.80)] and HAART discontinuation (aOR, 1.42; 95% CI, 1.17-1.72).25 A 
prospective study of 961 HIV-infected women participating in the Women’s Interagency HIV 
Study examined the associations of race, sociodemographic, and behavioral characteristics with 
response to HAART. Approximately 50% of the women were classified as depressed (CES-D 
>16) at their last pre-HAART visit. Depression was found to be significantly associated with 
poorer virologic response (aOR, 0.81) and increased likelihood of immunologic failure (aOR, 
1.98). In addition, depression was significantly associated with a higher risk of all-cause death, 
unrelated to AIDS (aOR, 1.65).30 
 A cross sectional study among 887 HIV-infected patients receiving HAART in western 
Denmark and central Copenhagen, part of a large population-based cohort, reported depression 
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prevalence of 47%. Researchers found that depression was significantly associated with 
increased odds of virological failure (aOR, 2.09; 95% CI, 1.19-3.68).23 A study of 1910 HIV-
infected patients reported that the 16% of patients with depression, measured using the 
Composite International Diagnostic Interview, were significantly more likely to be non-adherent 
to ART medication during the week prior to interview in comparison to patients who were not 
classified as depressed.29 
 Given empirical evidence of associations of depression with non-adherence and 
immunological failure, treatment of depression may improve outcomes among HIV-infected 
persons. A retrospective cohort study of HIV-infected persons who received clinical services 
from Denver Health reported lower antiretroviral adherence among depressed patients not on 
antidepressant treatment compared to depressed patients on antidepressants (P = 0.012).69 
However, antidepressant non-adherence and concurrent substance abuse can obstruct the efficacy 
of antidepressants.26 Additional studies assessing the association between antidepressants and 
ART adherence are needed, particularly among subpopulations with higher HIV prevalence. In 
addition, more approaches to alleviating mental illness should be explored. 
2.6 HIV Case Management Services 
 
 One potential resource for facilitating treatment of depression among HIV-infected 
persons is case management. Case management, as defined by the Commission for Case 
Manager Certification, is a ‘collaborative process that assesses, plans, implements, coordinates, 
monitors and evaluates the options and services required to meet the client’s health and human 
service needs’.70 A clear need for case management services persists among HIV-infected 
persons. In one study, depression and associated quality-of-life, coping strategies, social support, 
and use of health and social services were assessed among HIV-infected persons (N=297) in 
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Ontario, Canada. Results showed that depression was common (54.2%), and associated with a 
diminished health status. Depressed, HIV-infected persons used significantly more community-
based service organizations and crises centers. Findings suggested that caseworkers and service 
organizations could improve access to medications as well as quality of life for HIV-infected 
persons.71 
 The majority of studies examining case management services among HIV-infected 
persons assessed the impact of these services on linkage to care, unmet needs, utilization of ART 
medications, or clinical outcome indicators unrelated to mental health. In a 2005 study, recently 
diagnosed participants in the ARTAS study were randomized to either standard of care passive 
referral or case management for linkage to local HIV clinics. The study reported that a higher 
proportion of participants in the case-managed study arm (N=136) visited an HIV clinician in 
comparison to those in the standard of care arm (N=137) at least once within six months (78% 
vs. 60%; adjusted relative risk (aRR), 1.36; P = 0.0005, one-tail) and at least twice within twelve 
months (64% vs. 49%; aRR 1.41; P = 0.006, one-tail).12 A 2001 study assessed the efficacy of 
case managers on unmet needs and on utilization of medical care and ART medications among a 
national probability sample of HIV-infected persons (N=2437). Contact with a case manager at 
baseline was significantly associated with decreased unmet need for income assistance [odds 
ratio (OR), 0.54; 95% CI, 0.36-0.91], health insurance (OR, 0.54; 95% CI, 0.33-0.89), home 
health care (OR, 0.29; 95% CI, 0.15-0.56), and emotional counseling (OR, 0.62; 95% CI, 0.41-
0.94) at follow-up. In addition, contact with a case manager was associated with higher 
utilization of two-drug (OR, 1.58; 95% CI, 1.23-2.03) and three-drug (OR, 1.34; 95% CI, 1.00-
1.80) antiretroviral regimens at follow-up.72 
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In a cross-sectional study of 1133 HIV-infected individuals identified through outreach 
programs who knew their status and were not newly diagnosed, 12% had not received HIV 
medical care in the six months prior to the interview. In multivariable analyses, those with no 
care were less likely to have a case manager (p < 0.001) or use mental health services (p < .001), 
and had poorer mental health scores (p < 0.05).35 The ARTAS-II recruited HIV-infected persons 
from ten study sites in the US. Five sessions with a case manager were scheduled over a 90-day 
period. HIV-infected persons who had two-five sessions with a case manager were significantly 
more likely to engage in HIV care compared to those who had fewer than two sessions.19  
A 2013 study assessed linkage, retention in care, and viral suppression among newly 
diagnosed and prevalent HIV-infected persons identified from the District of Columbia 
Department of Health, which funds facilities to provide HIV case management. HIV-infected 
persons receiving care in facilities funded to provide case management were significantly more 
likely to be retained in care (aOR, 4.13; 95% CI, 1.93-8.85) than HIV-infected persons receiving 
care in facilities not funded to provide case management, though similarly likely to be virally 
suppressed (aOR, 1.06; 95% CI, 0.68-1.62).73 In another study, the health service utilization of 
72 subjects receiving directly administered HAART was analyzed for its effect on viral load at 
six-months. In adjusted multivariable analyses, case management services were significantly 
associated with virologic suppression at six months (aOR, 5.8; 95% CI, 1.1-30.5, P = 0.04).32  
Given the clinical benefits of case management services, it is essential that case 
management workers be adequately trained. A total of sixteen HIV/AIDS case managers across 
NC participated in a three-month case management training program and later enrolled clients 
who received adherence training. Data showed that case managers felt well positioned to provide 
services; however, common barriers were lack of reimbursement for their time, inadequate 
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training, and insufficient knowledge of HIV/AIDS and medications. Without appropriate training 
and resources, case managers may negatively affect client adherence, which may directly affect 
the client’s mental and clinical outcomes.74 
Further research on the various stages of the HIV continuum of care, including the 
potential benefits of case management services on management of depression and ART 
adherence, is desirable, particularly in Southern states experiencing a multitude of barriers to 
HIV medical care and higher incidence in subpopulations. NC has an integrated surveillance 
system with multiple programs collaborating to maximize disease prevention and treatment 
efforts. Educational guidelines for health professionals are established through the NC AIDS 
Education and Training Center (AETC) Program. Led by HIV clinical experts equipped to 
provide local training and education, this program was established by the Department of Health 
and Human Services (DHHS) and the Health Resources and Services Administration (HRSA). 
Clinicians receive technical and clinical information on services, such as PrEP, which is 
disseminated to the patient population.75 In addition to NC AETC, other targeted programs and 
HIV resources in North Carolina include partner notification, counseling and referral services, 
Care and Prevention in the United States, ADAP, and RW funding.41 The proposed research will 
use a subset of NC surveillance data to assist state public health officials to identify weak points 
along the HIV care continuum and help identify strategies for improvement.  
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CHAPTER THREE: RESEARCH PLAN AND METHODS 
 
3.1 Study Design Overview 
 
The two specific aims for this dissertation research are: 
Specific Aim 1. Estimate the cumulative incidence of persons initiating HIV medical 
care following diagnosis, examine patient-level sociodemographic and behavioral 
characteristics associated with delay in initiating care, and assess time to care initiation in 
relation to characteristics of the facility where HIV was diagnosed. 
Specific Aim 2. Estimate the prevalence of probable current depression and 100% ART 
dose adherence in the past three days in relation to case management utilization in the 
previous twelve months. 
Both aims were accomplished by analyzing NC data included in national surveillance systems 
developed by the US CDC. 
 For Aim 1 we analyzed population-based, surveillance data from the 2015 eHARS, a 
system developed by the CDC to enable states to collect and update sociodemographic and 
clinical data on HIV-infected persons. The state of NC requires named reporting of all HIV and 
AIDS diagnoses, all viral load and CD4 cell count values, all positive Western blot tests for HIV 
antibody, and all HIV genotypes.76, 77 Information on the type of testing facility at initial 
diagnosis and clinical time points, such as the date of initial HIV diagnosis and the date for the 
first viral load and/or CD4 count, are included in the eHARS dataset. 
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 For Aim 2 we analyzed data for 2009-2013 from the NC MMP. The MMP is a 
surveillance system designed to capture behavioral and clinical data from HIV-infected persons 
who have at least one HIV medical care visit during the survey window each year. MMP data are 
gathered from personal interviews with sampled patients and from abstraction of medical records 
3.2 Study Setting 
 
The NC Division of Public Health’s Communicable Disease Branch uses eHARS to 
monitor all persons either diagnosed with HIV in NC or diagnosed with HIV in another state and 
now living in NC. The state-run, population registry maintains risk factor information, 
HIV/AIDS diagnosis dates, residence at diagnosis, and testing site, for regular surveillance 
reporting to the CDC.  Selected laboratory values, including CD4 cell counts <200 cells/mm3 
and detectable viral loads, are also reported in eHARS. 
 MMP uses a 3-stage probability proportional to size sampling design to obtain nationally 
representative, annual cross-sectional samples of HIV-infected adults receiving outpatient HIV 
medical care in the United States.78-80 For each annual data collection cycle, US states and 
territories are sampled first, followed by outpatient facilities providing HIV care, and finally by 
HIV-infected adults aged 18 years and older who have at least one medical care visit in a 
participating facility during January – April of the respective collection year (Figure 3). All 50 
states, the District of Columbia, and Puerto Rico (defined as primary sampling units [PSUs]) are 
eligible for selection. For these PSUs, probability of selection is proportionate to the number of 
HIV-infected patients seen from January to April in the study year.78  
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Figure 3 Medical Monitoring Project, multi-stage sampling design, 2009-2013 
 
 Participating project areas include sixteen states (California, Delaware, Florida, Georgia, 
Illinois, Indiana, Michigan, Mississippi, New Jersey, New York, NC, Oregon, Pennsylvania, 
Texas, Virginia, and Washington), six separately funded large metropolitan areas (Chicago, 
Houston, Los Angeles County, New York City, Philadelphia, and San Francisco) within five of 
the sampled states, and Puerto Rico.68, 79 A facility sampling frame is developed in each of the 26 
project areas. An eligible facility provides HIV medical care, which is defined as having 
providers who prescribe antiretroviral therapy or order CD4 or HIV viral load tests. Only 
providers who manage their own patients’ HIV medical care are included in the facility sampling 
frame. Patients are then sampled from each facility with a third-stage sampling probability. Each 
patient sample is used for only one data collection cycle, with a new sample of patients drawn 
from participating facilities in each data collection cycle.79 For our research, we will only be 
utilizing MMP surveillance data from the state of NC. 
Stage 1: State/Territory ("Site")
Population: All U.S. States, D.C., Puerto Rico
Sample: 23 project areas (16 states, 6 separately-funded metropolitan areas, Puerto Rico)
Stage 2: Facility (Provider)
Population: Facilities providing HIV care in sampled state - large and small, public and private
Sample: ~40-60 facilities per project area 
Stage 3: Patient
Population: HIV-infected adults ≥ 18 years of age who received care at a sampled facility 
between January and the end of April
Sample: 0 - 125 patients per facility; 400 patients per site (minimum)       
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3.3 Study Population 
 
The study population for Aim 1 was drawn from all HIV-infected persons at least 18 
years of age, residing in NC and alive as of December 31, 2015 as recorded in eHARS.  
The study population for Aim 2 was drawn from respondents to the 2009-2013 MMP 
questionnaires. Respondents for each MMP annual data collection cycle were sampled to be 
representative of HIV-infected adults at least 18 years old, who had at least one medical care 
visit at a NC participating facility between January and April in a data collection year. The three-
stage sampling schema within NC for each year is provided below (Figure 4). While patients 
with complete interview and medical record abstraction (MRA) data were sampled, we only used 
interview data. Our MMP 2009-2013 analytical sample included a total of 910 respondents 18 
years of age or older – 602 males (67.2%), 297 females (31.3%), 10 transgender persons (1.3%), 
and 1 intersex person (0.1%).  
 
Figure 4 North Carolina Medical Monitoring Project sampling schema by year, 2009-2013 
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For each data collection year, the response rates among facilities and among patients in 
those facilities, adjusted for eligibility, were provided in the MMP response rate summary 
reports (Table 2). The facility response rate was calculated using the total number of eligible 
responding facilities and the total number of sampled participating eligible facilities. The 
adjusted patient response rate was calculated using the total number of sampled patients with 
overlapped interview data and MRA data, adjusted for eligibility. Although the response rates 
were lower than optimal, empirical research suggests that low response rates are not necessarily 
the result of nonresponse bias, particularly when probabilistic samples are drawn from well- 
constructed sampling frames.81, 82 
Table 2  Summary of North Carolina response rates, 2009-2013 
MMP Cycle 
Facility Response 
Rate 
Patient Response 
Rate 
Combined 
Response Rate* 
2009 72.22% 54.61% 39.44% 
2010 66.67% 45.55% 30.37% 
2011 60.00% 43.77% 26.26% 
2012 68.42% 45.13% 30.88% 
2013 87.50% 55.44% 48.51% 
* = Facility response rate times patient response rate 
Response rates provided by 2009-2013 MMP Response Rate Summary Reports83 
3.4 Data Collection 
 
enhanced HIV/AIDS Reporting System (eHARS) 
 Information obtained from each person diagnosed with HIV in NC is entered into a case 
report, which is then entered into eHARS. The data captured include the date of HIV diagnosis 
and clinical values and dates, obtained from laboratory testing such as CD4 counts and viral 
loads. Demographic and behavioral patient data include age, sex, race/ethnicity, and HIV 
transmission mode. The testing facility at initial HIV diagnosis was also recorded for most 
persons. 
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Medical Monitoring Project (MMP) Questionnaire 
 The most updated version of the MMP questionnaire used in our analyses had twelve 
sections. The first section (I) included participant identification (ID), facility ID, and the type and 
date of the interview. The next section (D) covered participant demographic characteristics such 
as type of residence, age, gender, education status, sexual orientation, and health insurance 
status. Participants were then asked to provide feedback on access to care (section A), including 
HIV testing and care experiences, sources of care, and met and unmet needs. The next section 
(R) gathered information on stigma and discrimination; quite often, HIV-infected individuals 
experiencing stigma and discrimination have difficulty taking prescribed HIV treatment 
medication and remaining adherent, which were ascertained in section T.  
 The largest portion of the questionnaire (section S) gathered information regarding sexual 
behaviors, including number of sex partners and types of sexual activity. In section U 
respondents reported on cigarette and alcohol use, non-injection drug use, and injection drug use. 
Section B assessed transmission risk factors, including questions about how participants may 
have acquired HIV and about their past partners’ behaviors.  
Sections P and M gathered information regarding prevention activities and depression, 
respectively. Depression was measured by asking the participant questions about his/her overall 
mood using the eight-item Patient Health Questionnaire depression scale (PHQ-8). This scale has 
been established as a valid diagnostic measure for depressive disorders in large population-based 
studies.84  
 The final two sections of the MMP questionnaire gathered information on respondents’ 
gynecological and reproductive history (section G) and health conditions and preventive therapy 
(section C). Female respondents provided information regarding pelvic exams, Pap smears, 
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pregnancies and pregnancy outcomes. Specific health condition and preventive therapy questions 
included CD4 and VL dates, vaccination history and STD testing and diagnoses. An additional 
interview completion portion of the questionnaire (section E) confirmed respondent 
compensation, reassured confidentiality, and assessed the interviewer’s confidence in the validity 
of the respondent’s answers. 
Medical Record Abstraction (MRA) – MMP Data 
 Though MRA data was not used in our analyses, these data were obtained from the 
medical charts of study participants with completed interview data to form an overlap dataset. In 
general, the MRA data gather the following information on respondents: patient demographics, a 
comprehensive medical history to include disease diagnoses and surgical histories, AIDS 
defining opportunistic illnesses, prophylaxis, hepatitis/toxoplasma/tuberculosis screening, 
immunizations, antiretroviral therapy, laboratory test results, HIV antiretroviral resistance 
testing, substance abuse, and mental health with an additional field for clinical notes and 
remarks.  
Data Acquisition and Approval 
 eHARS and MMP data were made available through the NC Division of Public Health, 
Epidemiology Branch. A data use agreement (DUA) between the Division of Public Health and 
the University of North Carolina at Chapel Hill on behalf of the author of this dissertation 
authorized provision of data sets containing de-identified, protected health information. 
Appropriate safeguards (secured storage on an encrypted drive) were used to protect the data 
from misuse or inappropriate disclosure. All publications and/or presentations derived from the 
data provided under the DUA are to undergo the Division of Public Health, Epidemiology 
Section’s clearance process. 
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 The CDC have determined that MMP is a public health surveillance activity.85 Because 
eHARS and MMP are not considered research, they are not subject to human subjects 
regulations including federal institutional review board (IRB review).86 Funding for the MMP in 
NC was provided by a cooperative agreement (PS09-937) from the CDC. This doctoral 
dissertation does require oversight by the IRB at the University of North Carolina at Chapel Hill. 
The IRB determined that the dissertation research was exempt from full review because it is an 
activity using de-identified, secondary data conducted for public health purposes (IRB Review #: 
14-2675). 
3.5 Sample Weights 
 
  The MMP data were collected using a complex, multi-stage sampling scheme, which 
requires special analytical procedures.87-91 Unequal selection probabilities, which necessitated 
weighted analysis, and appropriate methods for variance estimation were employed. The MMP-
provided sample project area weights (pa_wgt_over), which adjust for nonresponse, and project 
area strata (pa_strat) and cluster (pa_clust) variables, which account for the design complexity, 
were applied to univariable, bivariable, and multivariable analyses using SAS 9.4, Cary, NC. 
3.6 Analytic Methods 
3.6.1 Patient and facility characteristics and time to HIV medical care initiation (Aim 1) 
 
Measurements 
Outcome: Time to initiation of HIV medical care was defined as the number of calendar 
days from the date of initial HIV diagnosis (‘Day 0’) to the date of the first CD4 or VL 
measurement. We calculated cumulative incidence of care initiation at various time points and, 
consistent with earlier studies,10, 16, 20, 61 focused on delayed initiation defined as a first CD4 or 
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VL data ≥ three months since the date of HIV diagnosis (or no evidence of care) versus an earlier 
date. 
Exposure: Patient-level characteristics. In relation to time to HIV care initiation, we 
examined age at initial HIV diagnosis (categorized at approximate quartiles: 17-24 years, 25-30 
years, 31-44 years, and 45+ years), sex at birth (male, female), and race/ethnicity (non-Hispanic 
white, non-Hispanic black, and Hispanic/other). Due to small sample sizes, HIV-infected persons 
identifying as American Indian/Alaskan Native, Asian, Native Hawaiian/Pacific Islander, and 
multi-race were included in the Hispanic/other category. The following CDC hierarchical HIV 
transmission exposure categories were analyzed in relation to care initiation: MSM, injection 
drug use (IDU; including MSM/IDU), heterosexual transmission, and unknown HIV exposure. 
Facility-level characteristics. We examined time to initiation of HIV care in relation to 
three characteristics of the facility at which the HIV diagnosis was made: whether HIV medical 
care was available at the facility (co-located HIV medical care), the total number of HIV 
diagnoses reported from the testing facility in 2015 (facility diagnosis volume, categorized at 
approximate quintiles), and a six-category version of the facility type code from eHARS. 
Descriptions of the strata of each facility characteristic are provided in Table 3. 
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Table 3 Classification of exposure 
Testing Facility at Initial HIV Diagnosis 
HIV medical care co-location 
- Site without co-located HIV medical care 
- Site with co-located HIV medical care (referent category) 
Testing facility HIV diagnosis volume 
- 15+ HIV diagnoses 
- 7-14 HIV diagnoses 
- 4-6 HIV diagnoses 
- 2-3 HIV diagnoses 
- 1 HIV diagnosis (referent category) 
Testing facility type 
- Other/non-traditional* 
- STD clinic 
- HIV counseling & testing site 
- Inpatient hospital 
- Outpatient clinic 
- Outpatient private physician’s office (referent category) 
* Includes jails, prisons, blood bank and plasma centers, lab testing facilities, community centers, social service 
 organizations, military processing centers, and university student health centers. 
 
Data Analysis 
All variables other than time to initiation of care were coded as dichotomous, nominal, or 
ordinal categorical variables. ORs and 95% CIs were calculated using unconditional logistic 
regression for bivariable associations of delayed entry into HIV medical care in relation to 
patient sociodemographic and behavioral characteristics and testing facility characteristics. ORs 
and 95% CIs were reported for comparability to published studies.10, 16, 61 We would expect the 
ORs to approximate relative risk estimates given a delayed initiation prevalence slightly greater 
than 10%. We tested for collinearity, but did not observe any, among patient and facility risk 
factors. Effect measure modification of the association between each patient and facility risk 
factor and delayed care initiation by each additional patient and facility risk factor was examined 
by comparing the Akaike Information Criterion (AIC) values of the reduced (main effects) and 
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full (main effects + interaction) models, where the model with the smaller AIC value was 
determined to have the better fit. This procedure indicated that including an interaction between 
sex and co-location of medical care improved model fit.  
We then used multivariable unconditional logistic regression with a backward elimination 
modeling strategy with Wald chi-squared test p < 0.10 for retention to identify patient and 
facility risk factors independently associated with delayed entry into HIV medical care. The 
adjusted coefficients for facility volume displayed a clear dose-response relationship, so we 
elected to retain that variable despite its p-value of 0.25. Thus, all coefficients for patient and 
facility characteristics were adjusted simultaneously for the other characteristics, in a single 
multivariable, logistic regression model that included an interaction term for sex at birth with 
HIV co-location.  
The Kaplan-Meier non-parametric product limit estimator was used to estimate the 
cumulative incidence of HIV care initiation according to days since HIV diagnosis. Persons 
either initiated care or were censored at the end of the date range for the data (June 15, 2016). 
The graphs of the cumulative incidence of HIV care initiation were stratified by testing facility 
characteristics: HIV care co-location, facility HIV diagnosis volume, and testing facility type. 
Facility HIV diagnosis volume was collapsed into low-volume (1-3 HIV diagnoses), medium-
volume (4-14 HIV diagnoses), and high-volume (15+ HIV diagnoses) categories. 
Of 1,269 participants, 14.1% (N=179) were diagnosed in a hospital as inpatients, and 
approximately 3.0% (N=33) had an initial HIV diagnosis occur in the emergency room (ER). 
Because some have argued that CD4/VL testing performed during an acute hospitalization or ER 
visit may not represent true HIV care initiation,92 we conducted a sensitivity analysis that 
excluded these persons. All analyses were performed using SAS 9.4 (SAS Institute Inc., Cary, 
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NC). The IRB at the University of North Carolina at Chapel Hill determined that these analyses 
of data collected for public health surveillance purposes were exempt from full review (IRB # 
14-2675). 
3.6.2 HIV Case Management Utilization and Depression (Aim 2) 
 
Measurements 
Outcome: Depression was identified from responses on the PHQ-8.84 The PHQ-8 assigns 
a score for the number of days in the previous two weeks that the respondent experienced each of 
the eight criteria for depression from the Diagnostic and Statistical Manual of Mental Disorders, 
fourth edition (DSM-IV).93 Probable, current depression (we combined major with other) was 
defined based on Kroenke and Spitzer’s 2002 algorithm of experiencing at least two depressive 
symptoms for “more than half the days” in the preceding two weeks, with at least one symptom 
being depressed mood or anhedonia. This diagnostic algorithm yields comparable judgments to a 
total PHQ-8 score of ≥ 10, which we also examined.84, 94  
The prevalence of self-reported 100% ART dose adherence in the past three days was 
estimated using AIDS Clinical Trials Group measures.95 ART dose was defined as either a single 
tablet or multiple tablets taken concurrently. At the time of interview, participants were asked, 
“In the past three days, were you 100% dose adherent to your ART medicine?” If the respondent 
missed part of a dose, they were instructed to report that incident as a missed dose. HIV-infected 
participants were recorded as either 100% ART dose adherent or not 100% ART dose adherent 
in the past 72 hours. We also analyzed the MMP question about ART schedule adherence. 
Exposure: The exposure for aim two was utilization of case management services in the 
twelve-month period prior to the participant interview date. Case management services were 
examined dichotomously (Yes = 1, No = 0). 
 33
 Additional covariates: Various characteristics were considered as potential correlates 
and/or effect measure modifiers of the associations between utilization of case management 
services in the previous twelve months and 1) probable current depression, and 2) 100% ART 
dose adherence in the past three days. Sociodemographic risk factors included age at interview 
(18-29, 30-39, 40-49, ≥ 50 years), gender (male, female, transgender/intersex), race/ethnicity 
(non-Hispanic white, non-Hispanic black, Hispanic/Latino, other), sexual orientation 
(heterosexual, homosexual, bisexual, other/unclassified), education (< high school, high school 
or equivalent, > high school), yearly household income ($0-$19,999, $20,000-$39,999, $40,000-
$74,999, ≥ $75,000), federal poverty level (living at or below, versus above, the poverty level, 
defined per 2012 standards using household income and size),96 and health insurance (public or 
private, RW/ADAP only, uninsured). Because NC has many rural areas requiring long travel 
distances to visit medical providers, we examined the need for transportation assistance services 
in the previous twelve months (yes/no). Behavioral risk factors examined included alcohol 
consumption in the previous twelve months and current smoking status (yes/no). 
Data Analysis 
The distributions of sociodemographic and behavioral variables, the utilization of case 
management services in the previous twelve months, probable current depression, and 100% 
ART dose adherence in the past three days were summarized with unweighted counts and 
weighted percentages. All variables were coded as dichotomous, nominal, or ordinal categorical. 
Rao-Scott chi-square statistics accounting for survey design, and prevalence ratios (PRs) with 
95% CIs were calculated for bivariable associations of sociodemographic and behavioral 
characteristics with 1) case management utilization in the previous twelve months, 2) probable 
current depression, and 3) 100% ART dose adherence in the past three days.  
 34
Effect measure modification was examined for each variable using a product interaction 
term and an adjusted Wald test with a 0.15 significance level. Potential confounders of the 
relation between case management utilization and probable current depression (Figure 5), as well 
as ART dose adherence (Figure 6), were selected a priori from literature and with the use of a 
directed acyclic graph (DAG). Adjusted PRs and 95% CIs were calculated using multivariable 
Poisson models with robust variance to account for violations of the distribution assumptions. 
We assessed possible collinearity among variables using variation inflation factors; no 
collinearity was noted. Analyses were performed using Stata version 14 (StataCorp, College 
Station, TX) and SAS 9.4 (SAS Institute, Cary, NC). Except where noted, all analyses 
incorporated the MMP-provided sample design and weights, to account for clustering, unequal 
selection, and nonresponse. 
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Figure 5 Causal diagram of the relationship between the receipt of case management 
services in the previous twelve months and probable, current depression 
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Figure 6 Causal diagram of the relationship between the receipt of case management 
services in the previous twelve months and ART dose adherence 
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CHAPTER FOUR: DELAYED INITIATION OF HIV MEDICAL CARE AND 
ASSOCIATED PATIENT AND FACILITY CHARACTERISTICS AMONG ADULTS 
NEWLY DIAGNOSED WITH HIV IN NORTH CAROLINA 
 
4.1 Background 
 
Approximately 1.2 million people in the US were living with HIV as of 2015.37 Although 
new HIV diagnoses declined 19% between 2005 and 2014,37 incidence rates remain high among 
MSM (67% of incident cases), non-Hispanic blacks (45% of incident cases), Hispanics/Latinos 
(24% of incident cases), and residents of the South (HIV incidence 16.8 per 100,000 persons). 
Incidence rates (per 100,000 people) in the Northeast, West, and Midwest are lower at 11.6, 9.8, 
and 7.6, respectively.37, 97   
 The NHAS: Updated to 2020 outlines strategic initiatives to prevent the spread of HIV. 
First put forward in 2010, the main goals of the Strategy are to improve the national response to 
the epidemic by reducing new HIV infections, increasing access to care while optimizing health 
outcomes, and reducing HIV-related health disparities and inequities.50, 98 Given persistent 
transmission among specific demographic and geographic subpopulations despite increases in 
HIV testing rates, the 2020 update emphasizes improving key components of the HIV care 
continuum, namely timely initiation of HIV medical care upon diagnosis, prescription of and 
adherence to ART, retention in care, and achievement of viral suppression.21, 50  
 Focusing on each step of the HIV care continuum will help to identify and alleviate 
barriers to HIV care engagement and retention. Persons living with HIV in Southern states, 
especially, face major challenges to HIV care initiation due to shortages of trained medical and 
mental health professionals,40, 46 lack of personal or public transportation,40, 46 high STD rates 
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and poor medical infrastructures,39, 40, 62 racial disparities,62, 99 limitations in access to care due to 
lack of health insurance,62 and few systems of support and counseling.45 By 2013, NC met the 
2015 NHAS goal of increasing HIV testing (ever tested) by four percentage points, from 44.2% 
to 48.4%.100 Timely initiation of HIV care, with ART, significantly reduces the rate of HIV 
transmission 51 and also maximizes the benefits of treatment for the patient.98 
Several studies have assessed delay in initiating HIV care following HIV diagnosis.7, 9, 10, 
16, 20, 61 These studies have used various time intervals following initial HIV diagnosis 
(commonly three, six, and twelve months) and study populations, including patients identified 
from public health surveillance in US cities and national probability samples of persons in care, 
to examine patient and testing facility characteristics as potential correlates of delayed care 
initiation. Patient-level characteristics associated with a delay (entry into HIV care three or more 
months after initial diagnosis) include male gender;16 black,61 Latino,61 and non-white race;20 
younger age;10 IDU;10, 20 MSM and IDU HIV transmission exposure modes;16 unemployment;16 
and birth outside of the US.20 The national ARTAS-II project reported that persons diagnosed at 
HIV testing sites with co-located HIV care services entered HIV care significantly earlier than 
persons diagnosed at sites without co-located care.101 In New York City, persons diagnosed at a 
community testing site,20 city correctional system,20 STD or tuberculosis clinic,20 or a non-
medical facility10 initiated HIV care later than persons diagnosed at a facility with co-located 
medical care.  
There are no statewide studies of delayed initiation of HIV care within the Southern US, 
a region plagued by poor health indicators and disproportionately affected by the HIV 
epidemic.39 We used population-based, state surveillance data for 2015 for NC, the state with the 
8th highest number of new HIV diagnoses that year,37, 97 to estimate the cumulative incidence of 
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persons initiating HIV care according to time since diagnosis, to examine patient-level 
sociodemographic and behavioral characteristics associated with delay in initiating care, and to 
assess time to care initiation in relation to characteristics of the facility where HIV was 
diagnosed.  
4.2 Methods 
 
enhanced HIV/AIDS Reporting System (eHARS) 
  
eHARS is a surveillance system developed by the CDC to enable states to collect and 
update sociodemographic and clinical data on persons living with HIV. The NC Division of 
Public Health’s Communicable Disease Branch maintains the NC eHARS. According to NC 
General Statute 130A, all clinicians or persons in charge of laboratories are required to report a 
HIV diagnosis to the local health director/health department within 24 hours.76 Laboratory 
results from tests to determine the absolute and relative counts for the T-helper (CD4) subset of 
lymphocytes and all results from tests to determine HIV VL are also required to be reported 
(10A NCAC 41A.0101 section b4).77 The Branch uses eHARS to maintain statistics on all 
persons either diagnosed with HIV in NC or diagnosed with HIV in another state and currently 
residing in NC. eHARS stores sociodemographic, geographic, and HIV transmission risk data as 
well as clinical laboratory testing dates and values. 
 
Study Population 
 
 We defined our target study population as all adults (age 18 years and above) newly 
diagnosed with HIV in NC between January 1 and December 31, 2015, and believed to be alive 
and residing in NC as of the end of 2015. According to the 2015 NC HIV/STD Surveillance 
Report, 1,345 persons (all ages) were newly diagnosed with HIV in the state during 2015.42 The 
NC Communicable Disease Branch provided an eHARS dataset with data for the 1,272 persons 
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meeting our inclusion criteria (age ≥18, NC residence through end of 2015). We excluded three 
patients missing information on key facility-level variables, leaving 1,269 persons.  
eHARS contains the date of each person’s initial, Western-blot confirmed HIV diagnosis. 
Reporting guidelines specify that the diagnosis date is the date that the specimen for an 
individual’s first positive HIV test result was drawn.102 The dataset also included the dates of the 
earliest and most recent CD4 counts and VL measurements through June 10, 2016. The earliest 
CD4 or VL measurement was treated as the person’s date of HIV care initiation. In the final 
dataset, 94 patients lacked any CD4 or VL measurement and were treated as having not entered 
care as of June 15, 2016 and censored on this date.  
Individual-level characteristics 
We examined age at initial HIV diagnosis (categorized into approximate quartiles: 17-24 
years, 25-30 years, 31-44 years, and 45+ years), sex at birth (male, female), and race/ethnicity 
(non-Hispanic white, non-Hispanic black, and Hispanic/other). Due to small counts, persons with 
HIV identifying as American Indian/Alaskan Native, Asian, Native Hawaiian/Pacific Islander, 
and multi-race were included in the Hispanic/other category. The following CDC hierarchical 
HIV transmission categories were utilized: MSM, IDU (including MSM/IDU), heterosexual, and 
unknown. 
Facility Characteristics 
We examined time to initiation of HIV care in relation to three characteristics of the 
facility at which the HIV diagnosis was made: whether HIV medical care was available at the 
facility (co-located HIV care), the total number of HIV diagnoses reported from the testing 
facility in 2015 (facility diagnosis volume), and the type of facility (e.g., STD clinic). 
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Testing Facility with Co-located HIV Care 
Co-located HIV care was defined as the presence of an onsite HIV medical provider who 
prescribed ART. Testing facilities in NC with co-located HIV care were identified using the NC 
ONE CALL HIV Provider Directory, which lists all licensed HIV medical providers and 
associated medical groups in the state by county. ONE CALL was developed in 2013 through a 
partnership between the Division of Infectious Diseases at the University of North Carolina at 
Chapel Hill School of Medicine and the Communicable Disease Branch of the NC Division of 
Public Health.103 By matching the names of testing facilities in the eHARS dataset with the ONE 
CALL provider directory, we coded all eligible persons in terms of whether their initial HIV 
diagnosis was made at a testing facility with co-located HIV medical care. 
Testing Facility HIV Diagnosis Volume  
 The annual HIV diagnosis volume for each eligible person’s testing facility at HIV 
diagnosis was categorized according to approximate quintiles: 1 HIV diagnosis, 2-3 HIV 
diagnoses, 4-6 HIV diagnoses, 7-14 HIV diagnoses, and 15+ HIV diagnoses. 
Testing Facility Type at Initial HIV Diagnosis 
 HIV testing facilities are assigned one of twenty-six codes in eHARS according to 
organizational and institutional characteristics. For our analyses, on the basis of these codes, we 
created six categories: (1) “Private physician’s offices” included licensed medical physicians and 
medical groups providing general or specialty medical care to ambulatory patients; (2) “STD 
clinics,” typically housed in county health departments, provided testing and treatment, or 
referrals for treatment, specifically for STDs; (3) “HIV counseling and testing sites,” 
predominantly housed within county health departments or non-profit community organizations, 
were operated to provide testing for HIV/AIDS and referrals for counseling and treatment; 
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(4) “Inpatient hospitals” included all NC hospitals providing inpatient medical care; 
(5) “Outpatient clinics” were facilities providing general or specialty medical care to ambulatory 
patients, including hospitals’ outpatient services, Departments of Veteran Affairs, and 
freestanding urgent care and medical centers; and (6) “Other” (or “Non-traditional testing 
facilities”) included all other facilities from which positive tests were reported, such as jails and 
prisons, blood bank and plasma centers, lab testing facilities, community centers, social service 
organizations, military processing centers, and university student health centers. Our “Other” 
facility type included the eHARS “Other” category as well as other facility types with fewer than 
50 reported patients. 
Time to Initiation of and Delayed Entry into HIV Medical Care 
 Time to initiation of HIV care was defined as the number of calendar days from the date 
of HIV diagnosis (‘Day 0’) to the date of the first CD4 or VL measurement. We estimated the 
cumulative incidence of care initiation at various time points and, consistent with earlier 
studies,10, 16, 20, 61 focused on delayed initiation defined as a first CD4 or VL ≥ three months since 
the date of HIV diagnosis (or no evidence of care initiation).  
Statistical Analysis 
 All variables other than time to initiation of care were coded as dichotomous, nominal, or 
ordinal categorical variables. ORs and 95% CIs were calculated using unconditional logistic 
regression for bivariable associations of delayed entry into HIV care in relation to patient 
sociodemographic and behavioral characteristics and testing facility characteristics. ORs and 
95% CIs were reported for comparability to published studies.10, 16, 61 We would expect the ORs 
to approximate relative risk estimates given a delayed initiation prevalence slightly greater than 
10%. We tested for collinearity using condition indices, but did not observe any, among patient 
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and facility characteristics. Effect measure modification of the association between each patient 
and facility characteristic and delayed care initiation by each additional patient and facility 
characteristic was examined by comparing the AIC values of the reduced (main effects) and full 
(main effects + interaction) models, where the model with the smaller AIC value was the best fit. 
We then used multivariable unconditional logistic regression with a backward elimination 
modeling strategy, with Wald chi-squared test p < 0.10 for retention, to identify patient and 
facility characteristics independently associated with delayed entry into HIV care. The adjusted 
coefficients for facility volume displayed a clear dose-response relationship, so we elected to 
retain that variable despite its p-value of 0.25. Thus, all coefficients for patient and facility 
characteristics were adjusted simultaneously for the other characteristics in a single 
multivariable, logistic regression model that included an interaction term for sex with HIV care 
co-location.  
The Kaplan-Meier non-parametric product limit estimator was used to estimate the 
cumulative incidence of HIV care initiation according to days since HIV diagnosis. Persons 
either initiated care or were censored at the end of the date range for the data (June 15, 2016). 
The graphs of the cumulative incidence of HIV care initiation were stratified by testing facility 
characteristics: HIV care co-location, facility HIV diagnosis volume, and testing facility type. 
Facility HIV diagnosis volume was collapsed into low-volume (1-3 HIV diagnoses), medium-
volume (4-14 HIV diagnoses), and high-volume (15+ HIV diagnoses) categories. 
Of 1,269 participants, 14.1% (N=179) were diagnosed in a hospital as inpatients, and 
approximately 3.0% (N=33) had an initial HIV diagnosis occur in the emergency room (ER). 
Because some have argued that CD4/VL testing performed during an acute hospitalization or 
emergency room visit may not represent true HIV care initiation,92 we conducted a sensitivity 
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analysis that excluded these persons. All analyses were performed using SAS 9.4 (SAS Institute 
Inc., Cary, NC). The IRB at the University of North Carolina at Chapel Hill determined that 
these analyses of data collected for public health surveillance purposes were exempt from full 
review (IRB # 14-2675). 
4.3 Results 
 
Patient and Facility Descriptive Characteristics 
 
The 1,269 persons newly diagnosed with HIV were largely male (80.2%), self-identified 
as non-Hispanic black (64.3%), and classified in the MSM transmission category (56.7%) (Table 
4). About one in six persons (N=205) were diagnosed at a facility with co-located HIV care. 
Patients received their HIV diagnosis at an outpatient private physician’s office (21.7%), STD 
clinic (18.4%), HIV counseling and testing site (14.1%), hospital (inpatient, 14.1%), outpatient 
clinic (9.5%), or at a non-traditional testing facility such as a blood bank, plasma donation 
center, jail, or prison (22.2%).  
Nearly all patients (N=1,175, 92.6%) had evidence of initiation of HIV care (median of 
16 days from date of diagnosis, ranging from 0 to a high of 407 for the right-censored 
distribution, IQR=35.0). Nearly two-thirds (63.8%, N=810) of patients had a care initiation date 
within one month after diagnosis, 267 (21.0%) initiated care between one and three months after 
diagnosis, and 98 (7.7%) initiated care after three months.  
The 98 patients with a care initiation date over three months after the diagnosis date were 
similar to the 94 (7.4%) patients with no date of care initiation across all patient and facility 
characteristics except transmission category (Table 4). Combining these two groups yields an 
overall percentage with delayed care of 15.1% (N=192). Those with delayed care were more 
likely to be younger, born male, non-Hispanic black. Delay was more common for persons 
 45
diagnosed at a facility without co-located HIV care, or at a facility other than a physician’s 
office, outpatient clinic. The proportion of persons with delayed care initiation was positively 
correlated with higher facility diagnosis volume.  
Patient and facility characteristics were associated with one another. For example, among 
facilities that reported 4-14 HIV diagnoses in 2015, the percentage with co-located HIV medical 
care (25.5%, not shown) was more than twice the corresponding percentages among facilities 
with a lower (9.7%) or higher HIV diagnosis volume (12.4%). Similarly, facilities that reported 
15 or more HIV diagnoses in 2015 were predominantly HIV testing and counseling sites (41.6%) 
and STD clinics (30.5%); only 12.8% of such facilities were hospitals diagnosing inpatients, and 
none was an outpatient clinic or physician’s office. Facility diagnosis volume was also related to 
the patient age, sex, race/ethnicity, and transmission category, with the highest volume category 
having proportionately more patients who were age 30 years or younger (55.6%), male (86.4%), 
non-Hispanic black (71.6%), MSM transmission risk (67.5%), and IDU (6.6%). Patients age 30 
years or younger comprised approximately two-thirds of patients diagnosed at STD clinics and at 
HIV counseling and testing sites, and nearly half of patients at facilities in the “other/non-
traditional” category, but were in the minority at other facility types. 
Risk Factors for Delayed Initiation of HIV Medical Care 
 
Patient-level 
 
In the adjusted analyses (N=1,269), individuals between the ages of 17 and 24 years at 
time of HIV diagnosis were more likely to have delayed entry into HIV care (aOR, 2.14; 95% 
CI, 1.26-3.63), as were persons 25 to 30 years of age (aOR, 1.99; 95% CI, 1.18-3.34), compared 
to persons 45 years and older (Table 5). Females were less likely to have delayed entry into care 
than males (OR, 0.59; 95% CI, 0.38-0.92). Although non-Hispanic blacks were more likely to 
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have delayed entry into care in the crude analysis, the association was substantially attenuated 
after adjustment (aOR, 1.14; 95% CI, 0.72-1.80, versus non-Hispanic whites). Compared to 
persons with MSM HIV transmission exposure, persons reporting unknown contact (aOR, 3.56; 
95% CI, 2.24-5.66) were more likely to have delayed entry into HIV medical care, as were 
persons acquiring HIV through IDU exposure (aOR, 2.73; 95% CI, 1.29-5.76). Associations 
between patient-level characteristics and delayed care initiation were similar in the sensitivity 
analysis that excluded 212 patients (16.7%) diagnosed in a hospital or ER setting; the largest 
difference was an aOR of 3.21 (95% CI, 1.47-7.00) for persons acquiring HIV through IDU 
exposure.  
Testing Facility Characteristics 
The time-to-event analysis suggested that persons diagnosed at a facility with co-located 
HIV care initiated care more quickly than persons diagnosed at a facility without co-located HIV 
care (Figure 7). When persons diagnosed in the hospital or ER were excluded resulting in 1,057 
persons (lower graph), Kaplan-Meier curves were similar, although diagnosis at a facility with 
co-located HIV care appeared to be slightly more advantageous in the first week after diagnosis 
compared to the original analysis (upper graph). In the original analysis, by one month post-
diagnosis, 70.3% of patients testing positive at a facility with co-located HIV medical care 
initiated HIV care, compared to 58.2% of patients diagnosed at a facility without co-located HIV 
medical care. However, the relationship between co-located care and delayed care initiation was 
substantially modified by sex. Males diagnosed in a facility without co-located HIV medical care 
had almost three times the odds of delayed care initiation as males diagnosed in a facility with 
co-located care (aOR, 2.94; 1.51-5.74), whereas among females there was no evidence that being 
diagnosed at a facility without co-located care increased the odds of delayed care initiation 
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compared to diagnosis at a facility with co-located care (aOR, 0.85; 95% CI, 0.28-2.52) (Table 
5). Associations were similar when persons with a hospital (inpatient) or ER diagnosis were 
removed in our sensitivity analysis (aOR for delayed care initiation comparing no co-located to 
co-located care in males, 2.59; 95% CI, 1.31-5.11; females, 0.80; 95% CI, 0.23-2.77). 
 Although patients diagnosed at a medium-volume facility (4 to 14 HIV diagnoses) had 
the quickest entry into HIV medical care initially, by the end of one month patients diagnosed at 
low-volume facilities (1 to 3 diagnoses per year) were most likely to have initiated care, with 
patients diagnosed at high-volume facilities (15 or more diagnoses) having the most delay 
throughout the first three months (Figure 8, Logrank p<0.0001). In our sensitivity analysis, 
diagnosis at a low-volume facility was most advantageous approximately one week after 
diagnosis as opposed to one month as observed when these persons were included in the main 
analysis.  
The clear monotonic association between testing facility HIV diagnosis volume and 
delayed entry into HIV care was somewhat muted after adjustment, but was still evident (Table 
5). Compared to patients diagnosed at facilities with one diagnosis, patients diagnosed at 
facilities with 15 or more diagnoses were most likely to have delayed entry into HIV medical 
care (aOR, 1.76; 95% CI, 0.99-3.11), and patients reported from facilities with 7 to 14 diagnoses 
had higher odds of delayed care initiation (aOR, 1.74; 95% CI, 0.98-3.09). For each facility 
volume category, crude and adjusted odds ratios in the sensitivity analysis were similar to those 
in the original analysis. 
 Figure 9 shows that the great majority (nearly 80%) of persons whose HIV was 
diagnosed as hospital inpatients received a CD4 or VL measurement within one week of 
diagnosis. Patients diagnosed at outpatient clinics and private physician’s offices also had high 
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care initiation; about 70% had received a CD4 or VL measurement by three weeks after 
diagnosis. The cumulative incidence of care initiation among those diagnosed at STD clinics, 
HIV counseling and testing sites, and other/non-traditional facilities appeared to plateau at 
around 65% by approximately two months after HIV diagnosis. Even after adjustment for patient 
and other facility characteristics, HIV diagnosis at a STD clinic (aOR, 3.64; 95% CI, 1.91-6.96), 
an HIV counseling and testing site (aOR, 3.12; 95% CI, 1.55-6.30), or other/non-traditional 
facilities (aOR, 3.12; 1.71-5.70) versus diagnosis at an outpatient clinic or private physician’s 
office remained strongly associated with delayed entry into HIV medical care. These 
associations were similar when we excluded the 212 persons diagnosed as hospital inpatients or 
in the ER.  
4.4 Discussion 
 
We analyzed surveillance data for all adults diagnosed with HIV in 2015 in NC, a 
Southern state ranking 8th in HIV diagnoses in 2015.104 This study is one of few to examine 
delay in HIV care initiation in this US region,14 where HIV transmission continues at a high 
level, and is also the first study to consider testing facility diagnosis volume as a possible factor 
associated with delayed initiation of HIV care. 
Published US estimates of delayed HIV care initiation, defined as three or more months 
since the date of initial HIV diagnosis, range from 17% to 29%.7, 9, 10, 16, 20, 61 In our study, only 
15.1% of newly diagnosed persons had not initiated care within three months (the percentage 
rose to 16.2% when we exclude persons diagnosed while hospital inpatients or in the ER). On the 
other hand, even with inclusion of these persons, only 63.8% of newly diagnosed NC residents 
initiated care within one month, considerably lower than the 2015 national goal of 85%.100 
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Younger age,62, 105 male gender,62, 105 minority race,39, 62, 105 and MSM,62, 106 are persistent 
risk factors for HIV infection in the US, particularly in the South. These factors are also 
associated with delayed entry into HIV care nationally.61 We found the same in NC during 2015 
for younger age, male sex, and non-Hispanic black race/ethnicity, but observed Hispanics and 
men with MSM transmission risk to have lower proportions with delayed initiation than other 
groups. 
Though identification of personal characteristics associated with delayed HIV care 
initiation aids understanding of why certain persons may delay entry into care, identification of 
facility-related factors may be more useful for designing interventions to expedite care initiation. 
Our finding of more rapid care initiation following diagnosis at a facility with co-located HIV 
medical care conforms with an earlier report from the ARTAS-II study.19 Our findings of greater 
delay following diagnosis at STD clinics, HIV counseling and testing sites, and other facilities 
that do not provide general medical care also echo reports of delayed HIV care initiation 
following initial HIV diagnosis at New York City STD/TB clinics and community testing sites.20  
In NC, timely linkage to care programs involving clinicians, bridge counselors, HIV/STD 
counselors, and case managers must be strengthened at facilities diagnosing mid-to-large size 
volumes of patients, particularly STD clinics, HIV counseling and testing sites, and “other” 
testing facilities (e.g., prisons, jails, correctional centers, plasma donation centers and blood 
banks, social service organizations, and drug treatment centers). Strategies to improve linkage to 
care include linkage coordinators familiar with local HIV primary care providers, arranging 
transportation and possibly accompanying clients to their first medical care appointment, and 
establishing relationships with case management agencies.101 Testing at an STD clinic or HIV 
counseling and testing site may foretell reduced access to subsequent medical care in comparison 
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to testing in inpatient or outpatient settings with onsite access to HIV providers. Additional 
assessment of potential patient-level risk factors such as income, poverty status, insurance 
coverage, educational attainment, geographic descriptive measures, and unmet psychosocial and 
social service needs is needed to further evaluate why patients may be at risk of delayed entry 
into HIV care in NC. 
The positive association we observed between facility HIV diagnosis volume and delay 
in care initiation, although weaker after adjustment, has policy implications. For example, 
monitoring care initiation times for the nine facilities reporting 15 or more HIV diagnoses/year 
could help to identify barriers affecting a large number of clients and help to target resources. 
Meanwhile, testing facilities with small patient volumes might benefit from an Internet-based 
referral system to refer patients to care, which would require moderate resources to institute 
statewide. 
Although our use of surveillance data is a strength in terms of population coverage, it is 
also a limitation with regards to the range of available variables and reliance on routine data 
collection, where the investigator has no opportunity to standardize or monitor procedures. For 
example, the date of initial HIV diagnosis may not always refer to the date when the first positive 
blood specimen was drawn, may not represent the first diagnosis,107 or might have been preceded 
by a positive rapid test that even if not formally diagnostic could nevertheless have prompted 
initiation of care. Also, our indicator of HIV care initiation – a date of CD4 count or VL 
measurement– may not reflect effective engagement in HIV primary care,108 although studies of 
clinical cohort data suggest reasonably strong agreement between routine HIV care visits and the 
presence of CD4/VL measures.109 Analysis of additional CD4 and VL dates not available in our 
dataset could improve determination of care initiation and retention. In addition, elimination of 
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persons concurrently diagnosed with HIV and AIDS may have more accurately elucidated the 
significance of CD4 and VL measurements in the hospital setting, where HIV may be detected in 
persons seeking evaluation of AIDS symptoms.  
All persons in our dataset were believed to have been living in NC as of December 31, 
2015, though the 94 persons missing care initiation dates may include persons who died or 
moved out of the state in 2016. Reliable estimates of delayed care initiation within facility types 
with small numbers of diagnoses, such as jails, will require accumulating data from multiple 
years. Also, some facilities assigned to the “other/non-traditional” category might be more 
properly classified elsewhere, which would provide more accurate assessments of the 
relationships between facility type and care initiation. Social desirability bias may have 
influenced self-reported HIV exposure classification. The NC ONE CALL HIV Provider 
Directory developed in 2013 may not contain all active HIV providers in 2015, leading to 
misclassification in our coding of co-located HIV medical care. 
Expanding HIV testing within health care organizations that also provide HIV care 
facilitates linkage to care following testing. But to identify many people with undiagnosed HIV – 
including large numbers of young adults, men, ethnic minorities, low income, and rural residents 
– testing outreach necessarily involves settings without co-located HIV medical care. The ability 
to invest in additional clinician staffing in such settings will be severely constrained; even 
facilities diagnosing a dozen HIV patients/year diagnose no cases most weeks. A statewide 
system that makes use of surveillance data on HIV diagnoses, CD4 counts, and VLs could 
monitor, facilitate, and assure that persons diagnosed with HIV are in care and virally 
suppressed. Since each new HIV infection averted will avoid some $300,000 in lifetime health 
care costs,110 even a small additional reduction in new HIV infections in NC could offset the cost 
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of such a system. Further exploration of sociodemographic and behavioral characteristics 
associated with delayed care initiation, unmet needs of newly diagnosed persons, and specific 
facility referral mechanisms would provide data with which to design such a system. Although 
continuing stigma around HIV is a major barrier, consideration should also be given to adapting 
wellness strategies used to promote care engagement for other health conditions, especially 
strategies that appeal to youth, such as mHealth.111 Continuing monitoring of surveillance data 
linking HIV diagnosis, stage at diagnosis, care initiation, and VLs will be important to achieving 
public health goals for HIV clinical care and prevention, as will addressing unmet needs of HIV 
patients and persons at elevated HIV risk.  
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Table 4 HIV medical care initiation by patient and facility characteristics, 2015 
 
Total* 
(%) 
Care Initiation    
< 3 months         
N (%)† 
Care initiation    
≥ 3 months       
N (%)† 
No evidence of 
care initiation 
N (%)† 
Total 1269 (100) 1077 (84.9) 98 (7.7) 94 (7.4) 
     
Age (at HIV diagnosis)     
     17-24 327 (25.8) 260 (24.1) 33 (33.7) 34 (36.2) 
     25-30 283 (22.3) 228 (21.2) 26 (26.5) 29 (30.9) 
     31-44 328 (25.9) 292 (27.1) 22 (22.5) 14 (14.9) 
     45+ 331 (26.1) 297 (27.6) 17 (17.4) 17 (18.1) 
     
Sex     
     Female 251 (19.8) 225 (20.9) 12 (12.2) 14 (14.9) 
     Male 1018 (80.2) 852 (79.1) 86 (87.8) 80 (85.1) 
     
Race/ethnicity     
     Non-Hispanic black 816 (64.3) 672 (62.4) 70 (71.4) 74 (78.7) 
     Hispanic/other 161 (12.7) 147 (13.7) 10 (10.2) 4 (4.3) 
     Non-Hispanic white 292 (23.0) 258 (24.0) 18 (18.4) 16 (17.0) 
     
Transmission exposure category‡     
     Unknown 333 (26.2) 269 (25.0) 23 (23.5) 41 (43.6) 
     Adult IDU 56 (4.4) 44 (4.1) 9 (9.2) 3 (3.2) 
     Adult Heterosexual 160 (12.6) 147 (13.7) 7 (7.1) 6 (6.4) 
     Adult MSM 720 (56.7) 617 (57.3) 59 (60.2) 44 (46.8) 
     
Facility HIV Provider Status§     
     Non co-located HIV medical care 1064 (83.9) 888 (82.5) 86 (87.8) 90 (95.7) 
     Co-located HIV medical care 205 (16.2) 189 (17.6) 12 (12.2) 4 (4.3) 
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Facility HIV diagnosis volume||     
     15+ diagnoses 243 (19.2) 188 (17.5) 27 (27.6) 28 (29.8) 
     7-14 diagnoses 238 (18.8) 196 (18.2) 21 (21.4) 21 (22.3) 
     4-6 diagnoses 241 (19.0) 206 (19.1) 17 (17.4) 18 (19.2) 
     2-3 diagnoses 264 (20.8) 234 (21.7) 18 (18.4) 12 (12.8) 
     1 diagnosis 283 (22.3) 253 (23.5) 15 (15.3) 15 (16.0) 
     
Facility type at initial diagnosis¶     
     Other/non-traditional facility 282 (22.2) 222 (20.6) 27 (27.6) 33 (35.1) 
     STD clinic 234 (18.4) 181 (16.8) 29 (29.6) 24 (25.5) 
     HIV counseling and testing site 179 (14.1) 138 (12.8) 23 (23.5) 18 (19.2) 
     Inpatient hospital 179 (14.1) 164 (15.2) 6 (6.1) 9 (9.6) 
     Outpatient clinic 120 (9.5) 114 (10.6) 4 (4.1) 2 (2.1) 
     Outpatient private physician's office 275 (21.7) 258 (24.0) 9 (9.2) 8 (8.5) 
* Column percentages     
† Care initiation defined as the number of days between initial HIV diagnosis and first CD4 and/or viral load  
   measure. Delayed initiation defined as care initiation ≥ 3 months (90 days). 
‡ IDU = injection drug users; MSM = men who have sex with men   
§ Co-located HIV medical care defined as a facility with an antiretroviral therapy provider.      
|| Facility volume defined as the total number of HIV diagnoses made at a facility in the year 2015. 
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Table 5 Patient and facility characteristics and delayed entry into HIV medical care, 2015 
 
N (%)* 
Care 
initiation        
≥ 3 months       
N (%)† 
OR (95%CI)‡ aOR (95% CI)‡ 
Total 1269 (100) 192 (15.1)   
     
Age (at HIV diagnosis)     
     17-24 327 (25.8) 67 (34.9) 2.25 (1.44-3.51) 2.14 (1.26-3.63) 
     25-30 283 (22.3) 55 (28.7) 2.11 (1.33-3.34) 1.99 (1.18-3.34) 
     31-44 328 (25.9) 36 (18.8) 1.08 (0.66-1.77) 1.06 (0.62-1.80) 
     45+ 331 (26.1) 34 (17.7) 1.0 1.0 
     
Sex     
     Female 251 (19.8) 26 (13.5) 0.59 (0.38-0.92)  
     Male 1018 (80.2) 166 (86.5) 1.0  
     
Race/ethnicity     
     Non-Hispanic black 816 (64.3) 144 (75.0) 1.63 (1.09-2.43) 1.14 (0.72-1.80) 
     Hispanic/other 161 (12.7) 14 (7.3) 0.72 (0.38-1.39) 0.54 (0.27-1.10) 
     Non-Hispanic white 292 (23.0) 34 (17.7) 1.0 1.0 
     
Transmission exposure category§     
     Unknown 333 (26.2) 64 (33.3) 1.43 (1.01-2.01) 3.56 (2.24-5.66) 
     Adult IDU 56 (4.4) 12 (6.3) 1.63 (0.84-3.20) 2.73 (1.29-5.76) 
     Adult Heterosexual 160 (12.6) 13 (6.8) 0.53 (0.29-0.97) 1.23 (0.60-2.53) 
     Adult MSM 720 (56.7) 103 (53.7) 1.0 1.0 
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Facility HIV Provider Status|| 
     Non co-located HIV medical care 1064 (83.9) 176 (91.7) 2.34 (1.37-4.00)  
     Co-located HIV medical care 205 (16.2) 16 (8.3) 1.0  
     
Facility HIV Provider Status, by Sex||     
     Female     
        Non co-located HIV medical care 204 (81.3) 21 (80.8) 0.96 (0.34-2.70) 0.85 (0.28-2.52) 
        Co-located HIV medical care 47 (18.7) 5 (19.2) 1.0 1.0 
     Male     
        Non co-located HIV medical care 860 (84.5) 155 (93.4) 2.94 (1.55-5.55) 2.94 (1.51-5.74) 
        Co-located HIV medical care 158 (15.5) 11 (6.6) 1.0 1.0 
     
Facility HIV diagnosis volume¶         
     15+ diagnoses 243 (19.2) 55 (28.7) 2.47 (1.52-4.00) 1.76 (0.99-3.11) 
     7-14 diagnoses 238 (18.8) 42 (21.9) 1.81 (1.09-2.99) 1.74 (0.98-3.09) 
     4-6 diagnoses 241 (19.0) 35 (18.2) 1.43 (0.85-2.41) 1.43 (0.81-2.51) 
     2-3 diagnoses 264 (20.8) 30 (15.6) 1.08 (0.63-1.85) 1.15 (0.65-2.03) 
     1 diagnosis 283 (22.3) 30 (15.6) 1.0 1.0 
     
Facility type at initial diagnosis     
     Other/non-traditional facility 282 (22.2) 60 (31.3) 4.10 (2.33-7.24) 3.12 (1.71-5.70) 
     STD clinic 234 (18.4) 53 (27.6) 4.44 (2.49-7.92) 3.64 (1.91-6.96) 
     HIV counseling and testing site 179 (14.1) 41 (21.4) 4.51 (2.47-8.23) 3.12 (1.55-6.30) 
     Inpatient hospital 179 (14.1) 15 (7.8) 1.39 (0.68-2.86) 0.99 (0.46-2.13) 
     Outpatient clinic 120 (9.5) 6 (3.1) 0.80 (0.31-2.08) 0.62 (0.23-1.68) 
     Outpatient private physician's office 275 (21.7) 17 (8.9) 1.0 1.0 
* Column percentages     
† Care initiation defined as the number of months between initial HIV diagnosis and first CD4 and/or viral load  
measure. Delayed initiation defined as care initiation ≥ 3 months. 
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‡ OR = odds ratio, aOR = adjusted odds ratio, 95% CI = 95% confidence intervals for risk factors remaining in 
final multivariable, logistic model; backward elimination criteria (p = 0.10 for retention) 
§ IDU = injection drug users; MSM = men who have sex with men   
|| Co-located HIV medical care defined as a facility with an antiretroviral therapy provider.  
¶ Facility volume defined as the total number of HIV diagnoses made at a facility in the year 2015. 
 
 5
8
Figure 7 Time to HIV medical care initiation by HIV medical care co-location, 2015 
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Figure 8 Time to HIV medical care initiation by testing facility HIV diagnosis volume, 2015  
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Figure 9 Time to HIV medical care initiation by testing facility type, 2015 
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CHAPTER FIVE: DEPRESSION, ART ADHERENCE, AND RECEIPT OF CASE 
MANAGEMENT SERVICES BY ADULTS WITH HIV IN NORTH CAROLINA, 
MEDICAL MONITORING PROJECT, 2009-2013 
 
5.1 Background 
 
As recently emphasized in the US NHAS: Updated to 2020, prompt diagnosis of HIV 
infection, timely linkage to and retention in care, ART adherence, and resources for unmet needs 
are important for effective HIV treatment and prevention. Primary NHAS goals include 
increasing the percentage of persons with HIV who are retained in HIV medical care to at least 
90%, and increasing the percentage who are virally suppressed to at least 80%.50  
 Depression, the most prevalent psychiatric disorder among persons with HIV other than 
substance use disorders, has important implications for patient retention, quality of life, and HIV 
transmission.26 Depression prevalence among persons with HIV engaged in HIV care is 20%-
30%,66 at least twice the depression prevalence in the general US population.68, 112 Depression 
and depressive symptoms are associated with poorer ART adherence,25, 29 which is associated in 
turn with virological failure23, 30 and poorer immunological outcomes,30 increasing the likelihood 
of poor health and HIV transmission.113 
 One approach both to facilitating treatment of depression and to improving ART 
adherence is the provision of case management services,70 which have been used to decrease 
unmet need for supportive services and to improve HIV medical care among persons with 
HIV.114, 115 Most studies assessing the effectiveness of case management for persons with HIV 
have described the ability of these services to increase linkage to care,12, 19, 35, 73 ART uptake,72 
and virologic suppression,32 and to decrease unmet need for emotional counseling.72 Few studies 
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have examined the relationship between case management services and current depression or 
depressive symptoms among persons with HIV.116 In addition, the role of case management 
services in facilitating ART adherence has not been well established.117, 118 
In NC, case management services are offered to clients based on apparent need and 
availability of services. The services may be provided through the RW HIV/AIDS Program, 
which provides funding for state and local programs to assist low-income persons with HIV 
through medical case management, oral health management, home health care, transportation 
assistance, hospice care, and the ADAP.119 Public health officials continue to see increases in the 
HIV burden among low-income residents in Southern states, where financial strain, psychosocial 
trauma, substance use, and long travel distance to providers are correlated with a high prevalence 
of mental health illnesses.120 Improved understanding of the relationships between case 
management service provision and both depression and ART adherence is needed, particularly 
among persons residing in regions with barriers to medical care access. 
We used 2009-2013 data from the MMP, a national survey of persons with HIV receiving 
medical care, to assess the prevalence and correlates of case management services, current 
depression, and ART adherence in NC.121 We also examined the associations between case 
management utilization and both depression and ART adherence in this setting, a southeastern 
state with one of the highest burdens of HIV in the country.104   
5.2 Methods 
 
Medical Monitoring Project (MMP) 
 MMP is a supplemental HIV surveillance system that uses a three-stage probability 
proportional to size sampling design to obtain nationally representative, annual cross-sectional 
samples of HIV-infected adults receiving outpatient medical care for HIV in the US. The multi-
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stage sampling schema and weighting procedures have been described in detail previously.78-80 
NC, considered a primary sampling unit, is one of 16 states sampled annually. For each of the 
five cycles of data we analyzed (annual cross-sections in 2009-2013), MMP first sampled 
outpatient facilities in NC, and then HIV-infected adults aged 18 years or older who had at least 
one medical care visit in a participating facility between January and April of the cycle year. 
Data were collected via face-to-face interviews between June of the cycle year and May of the 
subsequent year (e.g., 2009 cycle collection = June 2009 – May 2010). The overall response 
rates for 2009-2013, combining facilities and patients and adjusting for unknown eligibility, were 
39.4%, 30.4%, 26.3%, 30.9%, and 48.5%, respectively. The resulting interview data included a 
total of 910 HIV-infected respondents – 602 males (67.2%), 297 females (31.3%), 10 
transgender persons (1.3%), and 1 intersex person (0.1%). 
The first half of the twelve-section MMP questionnaire asked participants about 
demographic characteristics (including age, education status, and sexual orientation), personal 
experiences regarding access to HIV care, and related barriers (e.g., HIV testing and care 
experiences, met and unmet needs, stigma and discrimination, etc.). The second half of the 
questionnaire included questions on sexual behaviors, substance abuse, transmission risk factors, 
partners’ behaviors, gynecological and reproductive history, health conditions and preventive 
therapy, HIV prevention activities, and depression. 
Case Management Utilization, Depression, and ART Adherence 
 Case management utilization was assessed based on responses to the MMP question, 
“During the past 12 months, did you get case management services?” The questionnaire did not 
provide a specific definition for case management services or assess the reasons for receiving 
these services.  
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Depression was identified from responses on the PHQ-8.84 The PHQ-8 assigns a score for 
the number of days in the previous two weeks that the respondent experienced each of the eight 
criteria for depression from the Diagnostic and Statistical Manual of Mental Disorders, fourth 
edition.93 A 9th criterion assesses suicidal or self-injurious ideation. MMP omitted this question 
because interviewers were not trained mental health providers. Studies have shown that 
exclusion of the 9th item does not have considerable effects on scoring because self-injurious 
ideation is uncommon in the general population and in primary care settings.94, 122-126 Original 
validation studies have shown that the PHQ-8 is comparable to the PHQ-9, and identical scoring 
thresholds for measuring current depression can be used for both questionnaires.94 
 We defined depression as probable current depression (major or other) based on Kroenke 
and Spitzer’s 2002 algorithm of experiencing at least two depressive symptoms for ‘‘more than 
half the days’’ in the preceding two weeks, with at least one symptom being depressed mood or 
anhedonia. This diagnostic algorithm yields comparable judgments to a total PHQ-8 score of ≥ 
10,84, 94 which we also examined in sensitivity analyses. 
ART adherence was defined as 100% ART dose adherence in the past three days, an 
AIDS Clinical Trials Group measure.95 At the time of interview, participants were asked, “In the 
past three days, were you 100% dose adherent to your ART medicine?” ART dose was defined 
as either a single tablet or multiple tablets taken concurrently. If the respondent missed part of a 
dose, he or she was instructed to report this as a missed dose. HIV-infected participants were 
recorded as either 100% ART dose adherent or not 100% ART dose adherent in the past 72 
hours on the basis of this question. In sensitivity analyses, we also analyzed ART schedule 
adherence, which was based on the MMP question, “In the past three days, were you 100% 
schedule adherent to your ART medicine?” 
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Additional Measures 
 
 Various characteristics were considered as potential correlates and/or effect measure 
modifiers of the associations between utilization of case management services in the previous 
twelve months and 1) probable current depression, and 2) 100% ART dose adherence in the past 
three days. Sociodemographic factors included age (18-29, 30-39, 40-49, ≥ 50 years), gender 
(men, women, transgender/intersex), race/ethnicity (non-Hispanic white, non-Hispanic black, 
Hispanic/Latino, other), sexual orientation (heterosexual, homosexual, bisexual, 
other/unclassified), education (< high school, high school or equivalent, > high school), annual 
household income ($0-$19,999, $20,000-$39,999, $40,000-$74,999, ≥ $75,000), federal poverty 
level (living at or below, versus above, the poverty level, defined per 2012 standards using 
household income and size),96 and health insurance (public or private, RW/ADAP only, 
uninsured). Because NC has many rural areas requiring long travel distances to visit medical 
providers, we examined the need for transportation assistance services in the previous twelve 
months (yes/no). Behavioral factors of interest included alcohol consumption in the previous 
twelve months (yes/no) and current smoking status (yes/no). 
Analytical Methods 
 MMP respondents with missing or incomplete data on case management utilization, 
depression, or ART adherence were excluded from analyses using those variables. Patients not 
taking ART were excluded from the denominator for adherence percentages. The distributions of 
sociodemographic and behavioral variables, utilization of case management services in the 
previous twelve months, probable current depression, and 100% ART dose adherence in the past 
three days were summarized with unweighted counts and weighted percentages. All variables 
were coded as dichotomous, nominal, or ordinal categorical. Bivariable associations of 
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sociodemographic and behavioral characteristics with 1) case management utilization in the 
previous twelve months, 2) probable current depression, and 3) 100% ART dose adherence in the 
past three days were examined with Rao-Scott chi-square statistics that accounted for the survey 
design, and prevalence ratios (PRs) with 95% confidence intervals (CIs) obtained from weighted 
Poisson models with robust variance estimation.  
We estimated the association between case management utilization in the past twelve 
months and: 1) probable current depression and 2) 100% ART dose adherence, using weighted 
multivariable Poisson models with robust variance to account for violations of the distribution 
assumptions. Since associations in our cross-sectional data could reflect (1) targeting of case 
management services with respect to prior (unmeasured) depression and ART adherence status, 
as well as (2) any effects of past-year case management services on current depression and ART 
adherence status, our interest in estimating these associations was not to infer causality. Rather, 
our intent was to assess current unmet need for depression management and ART adherence 
support according to prior case management utilization, such that targets for future investigation 
and intervention could be identified. 
In model development, we identified potential confounders of the associations between 
case management and both depression and ART dose adherence based on a literature review and 
directed acyclic graphs.127 We assessed effect measure modification for each predictor variable 
in the models using a product interaction term and an adjusted Wald test with a 0.15 significance 
level.  We assessed collinearity among variables using variation inflation factors; none was 
noted. Analyses were performed using Stata version 14 (StataCorp, College Station, TX) and 
SAS 9.4 (SAS Institute Inc., Cary, NC). Except where noted, all analyses incorporated the MMP-
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provided sample design and weights, to account for clustering, unequal selection, and 
nonresponse. 
Ethics Statement 
 The CDC determined that MMP is a public health surveillance activity.85 MMP itself is 
therefore not subject to human subjects regulations including federal IRB review.86 Funding for 
the NC MMP was provided by a cooperative agreement (PS09-937) from the CDC. The IRB at 
the University of North Carolina at Chapel Hill determined that these analyses were exempt from 
full review (IRB # 14-2675). 
5.3 Results 
 
Patient Characteristics 
 
 HIV-infected adults receiving care in NC during 2009-2013 were predominantly age 40 
years and older (74.8%), men (67.2%), non-Hispanic black (61.6%), and heterosexual (59.3%) 
(Table 6). Slightly more than half (54.6%) had at least a high school education. A majority 
(62.6%) reported a yearly household income less than $20,000; 45.5% were living at or below 
the poverty level.96 Most (75.0%) reported having public or private health insurance coverage in 
the previous twelve months; 22.3% reported having only RW/ADAP coverage, and 2.7% (n=25) 
reported having no coverage. About one-fourth needed transportation assistance. A majority of 
patients used alcohol in the previous twelve months (64.0%); a large minority were current 
smokers (43.7%). Just over half of patients (53.2%) reported using case management services in 
the previous twelve months. Approximately one in five patients (21.7%) experienced probable 
current depression, and 87.0% of patients receiving ART reported being 100% ART dose 
adherent in the past three days. A total of 8.6% of participants were not receiving ART. 
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Factors associated with Case Management Utilization 
 Women were more likely to utilize case management services in the previous twelve 
months than were men (PR, 1.15; 95% CI, 1.01-1.31), as were patients with less than a high 
school education (PR, 1.43; 95% CI, 1.21-1.69, versus those with more education). Respondents 
living at or below the poverty level were more likely to receive case management services (PR, 
1.42; 95% CI, 1.22-1.66, versus those living above the poverty line). Patients who received 
assistance from RW/ADAP (versus private or public insurance), needed transportation assistance 
in the previous twelve months, or reported current smoking status were all more likely to have 
received case management services in the previous twelve months.   
Factors associated with Probable Current Depression 
 Women were more likely to be currently depressed (PR, 1.44; 95% CI, 1.17-1.77, versus 
men), as were those living at or below the poverty level (PR, 1.59; 95% CI, 1.15-2.19, versus 
those living above the poverty level) (see Table 7). The prevalence of depression was also 
greater for those who needed transportation assistance (PR, 1.66; 95% CI, 1.25-2.19), as well as 
current smokers (PR, 1.40; 95% CI, 1.07-1.85, versus non-smokers). Persons who received case 
management services in the previous twelve months were 41% more likely to be depressed (PR, 
1.41; 95% CI, 1.09-1.83, versus persons who did not). We found no associations between 
probable current depression and age, race/ethnicity, sexual orientation, education, income, health 
insurance status, or alcohol use (past twelve months). 
Factors associated with 100% ART Dose Adherence 
Women were less likely to report 100% ART dose adherence in the past three days (PR, 
0.92; 95% CI, 0.86-0.98, versus men), as were non-Hispanic blacks (PR, 0.92; 95% CI, 0.88-
0.96, versus non-Hispanic whites) (see Table 8). Respondents with less than a high school 
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education were 10% less likely (PR, 0.90; 95% CI, 0.83-0.98) to be adherent compared to 
individuals with at least a high school education. Persons living at or below the poverty level 
were 7% less likely (PR, 0.93; 95% CI, 0.87-0.99) to be adherent compared to persons living 
above the poverty level. Current smokers were less likely to be adherent compared to non-
smokers (PR, 0.91; 95% CI, 0.85-0.98). Patients reporting probable current depression were less 
likely to be adherent than those not experiencing probable current depression (PR, 0.92; 95% CI, 
0.86-0.99). We found no associations between 100% ART dose adherence in the past three days 
and age, sexual orientation, income, health insurance status, need for transportation assistance 
(past twelve months), or alcohol use (past twelve months).  
Multivariable associations 
 Poverty level was found to be a significant effect measure modifier of the association 
between case management utilization in the previous twelve months and probable current 
depression (Wald p-value = 0.02; N=58 respondents were missing data on poverty). After 
adjustment for gender, sexual orientation, education, annual household income, health insurance 
status, and need for transportation assistance, utilization of case management services in the 
previous twelve months was associated with probable current depression among persons living 
above the poverty level (aPR, 2.05; 95% CI, 1.25-3.36), but not among those living at or below 
the poverty level (aPR, 1.01; 95% CI, 0.72-1.43) (N=842; 10 participants were missing data on 
case management utilization and/or probable current depression) (see Table 9). Similar 
associations were obtained in sensitivity analyses where depression was defined as a PHQ-8 
score ≥ 10 (aPR, 2.05; 95% CI, 1.31-3.20 for above poverty level; aPR, 0.91; 95% CI, 0.64-1.30 
for at or below poverty level). 
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Adjusted for gender, race/ethnicity, education, annual household income, poverty level, 
health insurance status, need for transportation assistance (past twelve months), and probable 
current depression, 100% ART dose adherence did not differ between those who did or did not 
receive case management services in the past twelve months (aPR, 1.00; 95% CI, 0.95-1.05), nor 
did 100% ART schedule adherence (aPR, 1.01; 95% CI, 0.95-1.08) (N=812; 21 participants were 
missing data on case management utilization and/or ART adherence, and 77 were not taking 
ART). 
5.4 Discussion 
 
The Southern region of the US has disproportionately high HIV infection rates105 and 
greater political, societal, and structural barriers to optimal clinical outcomes and prevention of 
HIV transmission.62 This study is one of the first to report prevalence estimates of case 
management utilization, current depression, and ART adherence using representative data on 
persons with HIV receiving HIV care in a Southern state. 
 Among persons receiving HIV care in our setting, 53.2% reported receiving case 
management services in the past twelve months. It is difficult to place this estimate in context, 
since the only available national estimate – 56.5% – was reported from the 1996-1997 HIV Cost 
and Services Utilization Survey and pertained to a shorter six-month period prior to interview.72 
The probable current depression prevalence for persons with HIV in care in NC based on 2009-
2013 MMP data was 21.7%, which is somewhat lower than the 25.6% reported from national 
2009 MMP data.68 Both estimates are about twice their corresponding estimates among the 
general US population.112 
As is regularly observed,68, 128-130 women were more likely than men to suffer from 
probable current depression. Persons with HIV in care with a need for transportation assistance 
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were more likely to be depressed, consistent with prior studies of the relationship between 
mental illness and needs for supportive services.131, 132 We found no differences in depression in 
relation to sexual orientation. One study reported that gay, HIV-infected men living in non-
metropolitan areas were more likely to suffer from depression, which was largely driven by 
social constraints.133 We likely underestimated the proportion of persons with HIV in care who 
are MSM due to low patient response rates. 
Among patients with incomes at or below the poverty level, both receipt of case 
management services and depression prevalence were higher than among patients above the 
poverty level, but there was no association between case management and depression. By 
contrast, among patients with household incomes above the poverty level, receipt of case 
management services and current depression were positively associated. We speculate that the 
association among patients above the poverty level reflects the targeting of case management 
services to persons suffering from depression, whereas among those at or below the poverty line, 
case management services would be indicated for many reasons besides depression. In NC, 
persons with HIV living in poverty utilize case management services for access to medical care, 
food, job resources, shelter, and transportation. However, 32.3% of patients above the poverty 
level had yearly household incomes of $20,000 or less, so an array of unmet needs may be 
common for a sizeable minority of that group as well. 
The prevalence of self-reported 100% ART dose adherence in the past three days among 
persons receiving care in NC was high (87.0%), and similar to the 86.0% prevalence reported 
using national MMP data from the 2009-2010 cycle.134 Non-Hispanic blacks, women, and 
persons living at or below the poverty level were less likely to be 100% ART dose adherent, as 
also seen in the national MMP data.134 The 100% ART dose adherence prevalence estimates 
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were similar for respondents who received case management and those who did not (aPR, 1.00; 
95% CI, 0.95-1.05). It is possible that appropriately targeted case management services boosted 
adherence among persons who would otherwise have been non-adherent, but our cross-sectional 
design precludes estimation of such an effect. An important qualifier is that 8.6% of patients 
were not taking ART, conceivably because they did not perceive a need to initiate ART, were 
judged likely to have poor adherence, or were not treatment-eligible on the basis of clinical 
guidelines. 
The high prevalence of depression, even among those receiving case management 
services, warrants public health attention and suggests the need for additional resources for case 
managers, or more support from providers and mental health professionals. In a previous study, a 
sample of HIV/AIDS case managers across NC participating in a three-month intensive case 
management training and adherence program reported client-level challenges to adherence such 
as depression, which were often associated with geographic barriers (e.g., rural residents with 
transportation needs) and social isolation. Several case managers felt they were not 
knowledgeable about adherence coordination and counseling or ART medication.74 Meeting the 
mental health needs of persons with HIV requires accessible and effective mental health 
resources, working in coordination with case managers.  
A limitation of our study is its cross-sectional design, in which history of case 
management utilization, probable current depression status, and ART adherence were ascertained 
simultaneously. As noted above, if case management was targeted to the subset of persons above 
the poverty level that was depressed, their depression prevalence may have declined from even 
higher levels but still be higher than among patients to whom case management was not 
provided. Among persons living at or below the poverty level, an even higher percentage of 
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patients receiving case management might have been depressed without it. However, the cross-
sectional design does not allow us to disentangle the extent to which effect estimates reflect case 
management targeting versus case management effects. Direct assessment of the effectiveness of 
case management to facilitate depression treatment and ART adherence will require prospective 
measurement of all three factors and appropriate analytical methods to account for time-varying 
relationships, repeated intra-individual measures, and bidirectional causality.  
Another limitation of our study is that information was self-reported and therefore subject 
to potential social desirability and recall biases, particularly in the case of ART adherence 
reporting. Self-reported adherence is known to overestimate adherence and is the least accurate 
of all measures, however, it is commonly used in HIV clinical care for efficiency.135 In addition, 
we did not consider geographical data with respect to the participants’ residences. With 
inconsistent quality and accessibility of health care services in the South, location information 
may shed light on particular barriers faced by individuals in certain geographic regions within 
NC.39  
 Optimal HIV clinical and prevention outcomes require identifying HIV-positive persons, 
linking them to and retaining them in care, prescribing appropriate ART, maintaining adherence, 
and achieving and maintaining viral suppression. These processes, in turn, require addressing 
unmet needs and psychological wellbeing, monitoring their impacts on ART adherence, and 
ensuring the effectiveness of mental health and other medical services. Case management and 
mental health agencies must be adequately funded, monitored, and evaluated to ensure that 
persons with HIV in-care are receiving assistance to improve HIV-related health outcomes in 
cost-effective ways. 
  
 74
Table 6 Sociodemographic and behavioral characteristics of participants in the North 
Carolina Medical Monitoring Project, 2009-2013 
 
 Unweighted        
N 
Weighted    
%* 
95% CI§ 
Total N 910   
    
Age    
     18-29 52 6.1 (4.1-8.1) 
     30-39 164 19.1 (15.4-22.7) 
     40-49 307 34.1 (31.0-37.2) 
     ≥ 50 387 40.7 (36.1-45.2) 
    
Gender    
     Men 602 67.2 (63.8-70.7) 
     Women 297 31.3 (28.0-34.6) 
     Transgender 10 1.3 (0.48-2.29) 
     Intersex 1 0.1 (0.00-0.38) 
    
Race/ethnicity    
     Non-Hispanic white 267 29.4 (23.4-35.5) 
     Non-Hispanic black 561 61.6 (54.5-68.7) 
     Hispanic or Latino 25 2.9 (1.7-4.1) 
     Other 57 6.1 (4.2-8.1) 
    
Sexual orientation    
     Heterosexual 548 59.3 (54.0-64.7) 
     Homosexual 283 31.6 (26.4-36.8) 
     Bisexual 71 8.0 (6.1-9.7) 
     Other/unclassified 8 1.1 (0.3-1.9) 
    
Education    
     > High school 501 54.6 (48.6-60.6) 
     High school or equivalent 237 26.7 (21.5-31.9) 
     < High school 172 18.7 (15.4-22.0) 
    
Income (annual household)†    
     $0 - $19,999 538 62.6 (57.7-67.4) 
     $20,000 - $39,999 174 21.3 (18.6-24.1) 
     $40,000 - $74,999 94 11.1 (8.3-14.0) 
     ≥ $75,000 44 5.0 (3.2-6.8) 
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Poverty level†    
     Above poverty level 457 54.5 (50.2-58.9) 
     At or below poverty level 393 45.5 (41.1-49.8) 
    
Health insurance (past 12 months)†    
     Yes (Public or Private) 691 75.0 (70.9-79.0) 
     Uninsured (Ryan White/ADAP only) 192 22.3 (18.7-25.9) 
     Uninsured 25 2.7 (1.5-3.9) 
    
Needed transportation (past 12 months)    
     No 671 74.3 (71.0-77.6) 
     Yes 239 25.7 (22.4-29.0) 
    
Alcohol use (past 12 months)†    
     No 334 36.0 (31.9-40.1) 
     Yes 572 64.0 (60.0-68.1) 
    
Current smoker†    
     No 507 56.3 (51.8-60.8) 
     Yes 399 43.7 (39.2-48.2) 
    
Case management services (past 12 
months)† 
   
     No 433 46.8 (41.4-52.2) 
     Yes 474 53.2 (47.8-58.6) 
    
100% ART dose adherence (past 3 days)†‡    
     Yes, 100% ART dose adherent 709 79.6 (77.0-82.2) 
     No, not 100% ART dose adherent 106 11.9 (9.2-14.5) 
     Not taking ART 77 8.6 (6.1-11.0) 
    
Probable current depression†    
     No 706 78.3 (75.2-81.4) 
     Yes 197 21.7 (18.6-24.8) 
* Percentages are weighted to account for probability of selection and nonresponse 
† Frequencies do not add up to total sample size (n = 910) due to missing data  
‡ ART = antiretroviral therapy    
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Table 7 Probable current depression by sociodemographic and behavioral characteristics, North Carolina Medical Monitoring 
Project, 2009-2013 
 Probable Current 
Depression       PR (95% CI)† Χ2 p-value§ 
 N %* 
Total (N=900) 195 21.5   
     
Age     
     18-29 8 13.3 1.0 
0.27 
     30-39 39 23.0 1.72 (0.70-4.26) 
     40-49 73 24.4 1.83 (0.86-3.91) 
     ≥ 50 75 19.7 1.48 (0.69-3.17) 
     
Gender     
     Men 115 19.1 1.0 
< 0.01 
     Women 80 27.6 1.44 (1.17-1.77) 
     Transgender/Intersex 0 - -  
     
Race/ethnicity     
     Non-Hispanic white 63 23.2 1.0 
0.76 
     Non-Hispanic black 113 20.3 0.87 (0.65-1.18) 
     Hispanic or Latino 6 24.7 1.07 (0.52-2.18) 
     Other 13 23.9 1.03 (0.58-1.82) 
     
Sexual orientation     
     Heterosexual 124 22.8 1.0 
0.08      Homosexual 51 17.8 0.78 (0.62-0.98) 
     Bisexual/Other/unclassified 20 26.2 1.15 (0.79-1.68) 
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Education 
     > High school 98 19.8 1.0 
0.39      High school or equivalent 57 23.9 1.21 (0.95-1.54) 
     < High school 40 23.1 1.17 (0.78-1.74) 
     
Income (annual household)‡     
     $0 - $19,999 131 24.6 1.0 
0.07 
     $20,000 - $39,999 31 16.7 0.68 (0.42-1.08) 
     $40,000 - $74,999 11 14.1 0.57 (0.31-1.03) 
     ≥ $75,000 7 16.5 0.67 (0.34-1.34) 
     
Poverty level‡     
     Above poverty level 76 16.8 1.0 
< 0.01 
     At or below poverty level 104 26.7 1.59 (1.15-2.19) 
     
Health insurance (past 12 months)‡     
     Yes (Public or Private) 151 21.8 1.0 
0.90      Uninsured (Ryan White/ADAP only) 37 20.3 0.93 (0.66-1.31) 
     Uninsured 6 20.0 0.92 (0.42-2.00) 
     
Needed transportation assistance (past 12 
months) 
    
     No 124 18.4 1.0 
< 0.01 
     Yes 71 30.5 1.66 (1.25-2.19) 
     
Alcohol use (past 12 months)‡     
     No 78 23.2 1.0 
0.30 
     Yes 117 20.6 0.89 (0.71-1.11) 
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Current smoker‡ 
     No 92 18.2 1.0 
0.01 
     Yes 102 25.6 1.40 (1.07-1.85) 
     
Case management services (past 12 months)     
     No 77 17.6 1.0 
< 0.01 
     Yes 118 24.9 1.41 (1.09-1.83) 
* Percentages are weighted to account for probability of selection and nonresponse 
† PR = crude estimate of prevalence ratio (PR) and 95% confidence interval (CI) from Poisson regression 
‡ Frequencies do not add up to total depression sample size (N=195) due to missing data 
§  P-value from Rao-Scott chi square statistic 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 7
9
 
Table 8 100% ART adherence in the past three days by sociodemographic and behavioral characteristics, North Carolina 
Medical Monitoring Project, 2009-2013 
 100% ART Dose Adherence 
PR (95% CI)† Χ2 p-value§ 
 N %* 
Total (N=812) 706 87.0   
     
Age     
     18-29 35 86.5 1.0 
0.35 
     30-39 124 87.1 1.01 (0.87-1.16) 
     40-49 228 84.2 0.97 (0.85-1.12) 
     ≥ 50 319 89.3 1.03 (0.90-1.18) 
     
Gender     
    Men 487 89.3 1.0 
0.02     Women 212 82.4 0.92 (0.86-0.98) 
    Transgender/Intersex 7 71.1 0.80 (0.49-1.29) 
     
Race/ethnicity     
     Non-Hispanic white 230 92.3 1.0 
< 0.01 
     Non-Hispanic black 420 84.6 0.92 (0.88-0.96) 
     Hispanic or Latino 20 94.7 1.03 (0.92-1.15) 
     Other 36 79.6 0.86 (0.75-1.00) 
     
Sexual orientation     
     Heterosexual 415 85.5 1.0 
0.25      Homosexual 232 89.2 1.04 (0.99-1.10) 
     Bisexual/Other/unclassified 59 88.6 1.04 (0.95-1.13) 
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Education 
     > High school 407 89.4 1.0 
< 0.01      High school or equivalent 178 86.3 0.97 (0.91-1.02) 
     < High school 121 80.5 0.90 (0.83-0.98) 
     
Income (yearly household)‡     
     $0 - $19,999 409 85.3 1.0 
0.10 
     $20,000 - $39,999 134 85.6 1.00 (0.92-1.09) 
     $40,000 - $74,999 79 94.8 1.11 (1.03-1.19) 
     ≥ $75,000 37 91.7 1.08 (0.97-1.19) 
     
Poverty level‡     
     Above poverty level 375 89.6 1.0 
0.02 
     At or below poverty level 284 83.2 0.93 (0.87-0.99) 
     
Health insurance (past 12 months)     
     Yes (Public or Private) 536 87.0 1.0 
0.99      Ryan White/ADAP only 163 86.8 1.00 (0.94-1.06) 
     Uninsured 7 86.1 0.99 (0.78-1.25) 
     
Needed transportation assistance (past 12 
months) 
   
 
     No 531 88.0 1.0 
0.25 
     Yes 175 84.0 0.95 (0.88-1.04) 
     
Alcohol use (past 12 months)‡     
     No 262 85.9 1.0 
0.47 
     Yes 442 87.6 1.02 (0.97-1.08) 
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Current smoker‡ 
     No 413 90.4 1.0 
0.01 
     Yes 291 82.4 0.91 (0.85-0.98) 
     
Probable current depression‡     
     No 563 88.6 1.0 
0.01 
     Yes 140 81.6 0.92 (0.86-0.99) 
* Percentages are weighted to account for probability of selection and nonresponse; ART = antiretroviral therapy 
† PR = crude estimate of prevalence ratio (PR) and 95% confidence interval (CI) from Poisson regression 
‡ Frequencies do not add up to total 100% ART dose adherence sample size (N=706) due to missing data 
§  P-value from Rao-Scott chi square statistic 
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Table 9 Associations between utilization of case management services and probable current depression, and 100% ART dose 
adherence, North Carolina Medical Monitoring Project, 2009-2013 
 
 Probable Current 
Depression 
Prevalence
* 
PR aPR 
Total (N=842) Yes (N) No (N) %  (95% CI)  (95% CI)‡ 
Case management utilization (past 12 
months) 
     
At or below poverty level      
     Utilized case management 63 173 27.0 1.02 (0.73-1.44) 1.01 (0.72-1.43) 
     Did not utilize case management 41 112 26.4 1.0 1.0 
      
Above poverty level      
     Utilized case management 45 150 23.0 1.90 (1.26-2.87) 2.05 (1.25-3.36) 
     Did not utilize case management 31 227 12.1 1.0 1.0 
 100% ART Dose 
Adherence† 
Prevalence
* 
PR aPR 
Total (N=812) Yes (N) No (N) %  (95% CI)  (95% CI)§ 
Case management utilization (past 12 
months) 
     
     Utilized case management 374 64 85.6 0.97 (0.92-1.02) 1.00 (0.95-1.05) 
     Did not utilize case management 332 42 88.7 1.0 1.0 
* Percentages are weighted to account for probability of selection and nonresponse 
† 100% ART dose adherence (past three days); ART = antiretroviral therapy    
‡ Adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs) calculated using multivariable Poisson models 
adjusted for gender, sexual orientation, education, income, health insurance, need for transportation; analyses weighted to 
account for complex sample design 
§ Adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs) calculated using multivariable Poisson models 
adjusted for gender, race/ethnicity, education, income, poverty, health insurance, need for transportation, probable current 
depression; analyses weighted to account for complex sample design 
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CHAPTER SIX: DISCUSSION 
 
6.1 Overview 
 
According to the CDC, more than 1.2 million people in the US are currently living with 
HIV infection, and approximately 13% are unaware of their status.37 Incident cases declined 19% 
from 2005 to 2014, and testing rates increased.37 However, as of December 2016, MSM,37, 50, 104 
black and Latino men and women,37, 50, 104 injection drug users,37, 50 youth aged 13-24,37, 50, 104 
and transgender women are most affected by HIV.37, 50 In addition, HIV remains concentrated 
among persons living in the South.37, 50, 104 Particular challenges such as long travel distances to 
medical care,13, 136 poor healthcare infrastructures,62 stigma,62 states’ refusals to expand insurance 
coverage,62 disproportionate incarceration of black men,137, 138 poverty,137, 138 and racial 
discrimination137, 138 drive HIV transmission in this region. 
 As outlined in “The NHAS: Updated to 2020,” improvements are needed along the HIV 
care continuum.50 The continuum models the various HIV medical care stages an HIV-infected 
person needs to traverse from initial HIV diagnosis to maintenance of HIV viral suppression.21 
Beginning with testing and timely initiation of HIV medical care, by measuring the proportions 
of individuals engaged at each step, researchers and policy makers are able to identify gaps in 
care continuity and examine barriers to optimal care. In Southern states, patient and HIV testing 
facility characteristics associated with delayed care initiation are poorly described. This 
dissertation uses statewide surveillance data to assess time to initiation of HIV care in NC. 
Case management has been used as a strategy to decrease unmet need for supportive 
services and improve HIV medical care among HIV-infected persons.114, 115 However, few 
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studies have examined case management utilization in relation to mental health and its 
implications for ART adherence, necessary for viral suppression. This dissertation uses statewide 
data for NC to evaluate the receipt of case management support services for persons engaged in 
HIV care, and the relation of these services to patient quality of life and ART adherence. 
6.2 Summary of Findings 
 
Using surveillance data from eHARS for all adults diagnosed with HIV in NC and from 
the NC portion of MMP that surveys persons in HIV care in 26 project areas, our study examined 
two stages along the HIV care continuum. We first assessed time to care initiation and 
proportions of patients first accessing care within one month and three months from initial HIV 
diagnosis for persons newly diagnosed in 2015. We also examined patient and testing facility 
characteristics associated with delay in care initiation. Among all newly diagnosed persons 
(N=1,269), 63.8% initiated care within one month after diagnosis and 84.9% within three 
months. The median time to care initiation among the 92.6% of persons with evidence of care 
initiation was 16 days. Even if patients with no date of CD4 or viral load measurement in 
eHARS had in fact not accessed care by June 15, 2016, the estimate of 15.1% not initiating care 
within three months of diagnosis was somewhat lower than prevalence estimates of 17%-29% 
reported in previous literature,10, 16, 20, 61 but the one-month incidence of entry into care (63.8%) 
was considerably below the national goal of 85%.100 
 After adjustment for patient and facility characteristics, age 18-30 years (48% of patients) 
and male sex at birth (80% of patients) were associated with delayed initiation of HIV medical 
care. Non-Hispanic black ethnicity (about two-thirds of HIV infected persons in NC) was also 
associated with delayed care initiation, though the association was stronger before adjustment for 
facility type. 
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Initial diagnosis at a facility with co-located HIV medical care was associated with 
shorter time to care initiation among men, though not among women. Persons diagnosed at 
facilities reporting larger numbers of HIV diagnoses were more likely to have delayed care 
initiation. Persons diagnosed as hospital inpatients had the shortest intervals to first CD4 or viral 
load measurements, although additional investigation is needed to determine whether in the 
inpatient hospital context these tests do indeed indicate the initiation of continuing HIV care. 
Stratified analysis according to whether or not AIDS is diagnosed concurrently with HIV would 
also be informative. Compared to patients diagnosed at a hospital, outpatient clinic, or private 
physician’s office, patients initially diagnosed  at a STD clinic, an HIV counseling and testing 
site, or a facility in the “other” category (e.g., blood banks, jails, prisons) were significantly more 
likely to have delayed care initiation. These findings are consistent with a national study that 
observed delayed entry into care following initial HIV diagnosis at a STD clinic or a community 
testing site.20  
The statewide coverage of the eHARS database was a major strength of our study, but it 
also had several limitations: coverage was very incomplete prior to 2015, so data before that year 
are of limited utility. Surveillance data collects limited patient-level information, recording of the 
date of initial HIV diagnosis may not be fully standardized, date of first CD4 count or viral load 
measurement may not represent actual initiation of HIV care, and surveillance data may not have 
the same quality as data collected through a specific study (assuming adequate funding and 
quality control). 
 Further along the continuum, patients who have initiated HIV medical care may need 
support services to facilitate their remaining in care and adhering to ART in order to achieve the 
best clinical outcomes, extend survival, and minimize further HIV transmission. We used five 
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years of data (2009-2013) from the MMP survey of HIV-infected persons in HIV medical care in 
NC to estimate prevalence of case management utilization in the previous twelve months, 
probable current depression, and ART adherence, and to examine associations of case 
management utilization with current depression and ART adherence. 
 Just over half of patients (53.2%) reported receiving case management services in the 
previous twelve months, 21.7% experienced probable current depression, and 87.0% were 100% 
ART dose adherent in the past three days. These prevalence estimates were similar to case 
management utilization (56.5%)72 and 100% ART dose adherence estimates (86.0%)134 
previously reported using national survey data of HIV-infected persons in care, though the 
national estimate for case management refers to a shorter recall interval (past six months) some 
two decades ago. 
Our probable current depression prevalence estimate of 21.7% was slightly lower than 
the 25.6% estimate reported from the national 2009 MMP data.68 Women, persons living at or 
below the poverty level, respondents reporting the need for transportation assistance in the 
previous twelve months, and participants reporting current smoking were more likely to 
experience probable current depression. After adjustment for sociodemographic and behavioral 
characteristics, utilization of case management services in the previous twelve months was 
positively associated with probable current depression among persons living above the poverty 
level (aPR, 2.05; 95% CI, 1.25-3.36), whereas no association was observed among persons living 
at or below the poverty level (PR, 1.01; 95% CI, 0.72-1.43). 
Women, non-Hispanic blacks, respondents with less than a high school education, 
persons living at or below the poverty level, current smokers, and those experiencing probable 
current depression were less likely to be 100% ART dose adherent in the past three days. After 
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adjustment for gender, race/ethnicity, education, income, poverty level, probable current 
depression, need for transportation assistance in the past twelve months, and insurance coverage, 
there was no association between 100% ART dose adherence and receipt of case management 
services in the previous twelve months (aPR, 1.00, 95% CI, 0.95-1.05 for 100% ART dose 
adherence). Because of the cross-sectional design of the study, however, it is possible that case 
management services improved adherence in persons who would otherwise have been non-
adherent, resulting in there being no cross-sectional association between current adherence and 
history of case management services. In addition, the self-reported data were subject to potential 
social desirability and recall biases.  
6.3 Public Health Significance 
 
Scientific breakthroughs during the latter half of the 20th century – discovery of 
retroviruses, development of highly sensitive and specific biochemical antibody and antigen 
tests, development of highly effective ART with tolerable side effect profiles, and the 
demonstration that viral suppression dramatically reduces infectiousness – have given us the 
ability to control the HIV epidemic, preventing its further spread and enabling infected persons 
to live a full life. Parallel advances in societal acceptance of the need to address HIV as a public 
health problem have begun to create the opportunity to tackle this major pandemic. Realizing 
this opportunity requires closing the gaps in the HIV care continuum, from identifying all cases 
of HIV to ensuring viral suppression in those found to be infected. 
This dissertation has focused on the middle components of the care continuum: entry into 
HIV care and ART adherence among persons in care. Using NC data from two national 
surveillance systems – eHARS and MMP – we have assessed (1) timeliness of HIV care 
initiation in relation to patient and testing facility characteristics at initial HIV diagnosis, and (2) 
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indicators of effectiveness of HIV care among those already in care. Our findings for initiation of 
care indicate the need for substantial improvement in order to reach the “NHAS: Updated to 
2020” goal of 85% of newly-diagnosed patients initiating care within one month.100 By contrast, 
our findings for effectiveness of care show ART adherence in the NC MMP at about the same 
level as that in the national MMP. Given the various challenges HIV patients must navigate 
(rural distances, transportation, insurance, stigma, etc.), NC providers and the NC public may be 
reassured that patients in care are adherent as patients elsewhere in the country. But it is essential 
to remember that the MMP years in this study include only patients who are in care and have 
therefore surmounted these obstacles at least to some extent. A fuller analysis needs to account 
for infected persons not in care, which will become possible with versions of the MMP soon to 
become available. 
In general, patient needs for transportation and social services, as well as for care of 
medical conditions in addition to HIV, must be met through medical and support services to 
reduce HIV comorbidities such as depression and improve ART adherence rates. This study 
provides evidence that persons in care in NC have received support services appropriate for their 
needs. Case management services were received by a significant proportion (53.2%) of HIV-
infected persons covered by the MMP, especially women and persons with one or more of the 
following characteristics: less than a high school education, lower household income, 
RW/ADAP coverage only, need for transportation assistance, and current smokers. As expected, 
persons below the poverty level were both more likely to utilize case management services and 
to be currently depressed. Contrary to expectations, though, among persons above the poverty 
line, prevalence of current depression was significantly greater among those who reported having 
received case management services. However, that finding could reflect targeting of case 
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management services to persons suffering from depression or having other challenges that 
increase the risk of depression. The cross-sectional study design unfortunately made it 
impossible to distinguish among these possibilities.  
Similarly, though no difference in 100% ART dose adherence prevalence estimates was 
observed between respondents who did and respondents who did not receive case management 
services, it is possible that ARV adherence would be lower without case management. The 
overall prevalence of 100% ART dose adherence in the past three days, 87.0%, was nearly 
identical to the 86% adherence prevalence reported from national 2009 MMP data.134 
6.4 Future Research Directions 
 
 In NC, younger adults, males, and non-Hispanic blacks were more likely to have delayed 
entry into care after their initial HIV diagnosis, but additional, unmeasured patient characteristics 
may be more strongly associated with delayed entry into care for NC adults. Information on 
factors such as unmet needs for other medical services, stigma, insurance limitations, income 
shortages, and travel distance to HIV medical care may provide better indications of how to 
improve linkage to care programs. Researchers have previously reported that uninsured, HIV-
infected persons established in care in Philadelphia travelled further distances than persons with 
public insurance, which could pose a barrier to care continuity.13 An analysis using state-specific 
MMP data of persons established in care, which captures much of these data, would prove 
useful. 
 As infectious disease physicians and facilities become more available throughout NC, an 
updated analysis of the association between HIV medical care colocation and delayed entry into 
HIV medical care is warranted. Our HIV medical care colocation estimate likely underestimates 
the true number of sites with on-site HIV medical providers. Although the NC ONE CALL HIV 
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Provider Directory is no longer updated, the names of facilities reporting new HIV cases are 
collected in the NC eHARS data. These names can be used to develop an updated, more accurate 
count of facilities with on-site HIV medical providers.  
STD clinics, HIV counseling and testing sites, and facilities other than hospitals, 
outpatient clinics, and private physician’s offices were significantly associated with delayed 
initiation of care in NC. Further assessment of the latter facilities, including blood banks and 
prisons, is needed to identify barriers to care linkage among patients diagnosed in these facilities. 
Interventions to facilitate care initiation should be targeted to patients at high volume STD 
clinics and HIV counseling and testing sites. Lastly, analysis of eHARS laboratory data on 
multiple viral load measures would help determine which people with an initial measurement 
have truly entered HIV care and could also assess retention in care, which is essential to reduce 
transmission and improve clinical outcomes. 
 Our assessment of the utilization of case management services in the previous twelve 
months and associations with 1) probable current depression, and 2) 100% ART dose adherence 
was limited by the use of cross-sectional data. Thus, we were unable to exclude the possibility 
that higher current depression prevalence in association with receipt of case management in 
persons above the poverty level reflected targeting of case management. Similarly we could not 
assess whether 100% ART dose adherence was lower before case management provision. For the 
few participants in the MMP data reporting a need for case management services in the previous 
twelve months and an inability to receive these services, reasons for not receiving services were 
reported. In future research, reasons for case management utilization should also be reported to 
effectively evaluate the provision of services to HIV-infected clients. In addition, longitudinal 
data on recent utilization of case management, current depression, ART adherence, and viral load 
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assessed at least every six months would provide a better opportunity to evaluate the impacts of 
case management services for HIV patients in NC. Of course, such intensive data collection 
would be considerably more costly and logistically challenging. 
 North Carolina collects various data from HIV-infected persons using multiple data 
sources, including the North Carolina Electronic Disease Surveillance System, care system, 
eHARS, and MMP. The NC-LINK: Systems Linkage and Access to HIV Care in North Carolina 
project was funded from a HRSA Ryan White Special Projects of National Significance grant 
provided to the NC DHHS, Communicable Disease Branch.139 The project has a goal of 
increasing testing efforts, clinical lab reporting, and linkage to care rates, while improving 
coordination among HIV clinicians, counselors, and bridge counselors through the integration of 
NC data sources into one system called NC ECHO (Engagement in Care for HIV Outreach).139 
Analysis of this complete dataset would provide a new opportunity for continuous monitoring of 
the HIV care continuum in NC, with regular reporting of indicators at each stage. Maintaining a 
focus on all steps of the continuum – including a means of monitoring and minimizing the 
prevalence of undetected HIV infections – will facilitate realizing the opportunity that is now at 
hand to bring the HIV epidemic under control and to eventually eliminate it. 
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